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ABSTRACT 
Early Psychosis Programs have been developed as a solution to reduce delays and 
improve outcome for first episode psychotic patients. Evaluations of the programs 
worldwide have found that the programs help reduce symptoms and hospitalizations and 
improve quality of life. The purpose of this thesis is to evaluate the overall impact of the 
Newfoundland and Labrador Early Psychosis Program (NL Program) for its patients. 
Traditionally, programs are evaluated by pre-post methodology. However, this method 
may have limitations since it does not use standard control groups and any changes seen 
in the patients from entry to completion of the program may be due to natural events, 
such as maturation and changes in hormones, since the patients tend to be fairly young. 
Therefore, this study will test a novel methodology, propensity matching, as an 
alternative method to evaluate the NL Program. The patients are matched to a national 
population from the Canadian Community Health Survey (CCHS) on several clinical and 
social outcomes to determine how the patients differ from the general population at entry 
into the NL Program and then after two years, to see if they converge back to the 
population after completing the NL Program. Propensity matching results are then 
compared to the pre-post results. Analysis of the data found the propensity matching 
methodology did produce similar results as the pre-post evaluation approach on social 
and clinical outcomes such as reducing substance use, depression, hospitalizations and 
suicide, and improving quality of life and vocational functioning. In conclusion, this 
study found the NL Program is having a major treatment effect for its patients, and 
propensity matching may serve as a model in future evaluations in mental health 
research. 
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CHAPTER I 
INTRODUCTION TO THE PROBLEM: 
OUTCOME EVALUATION OF AN EARLY PSYCHOSIS 
PROGRAM USING PRE-POST COMPARSION AND 
PROPENSITY MATCHING 
1.1 Statement of the Problem 
Psychosis is a medical condition that affects the brain. First episode psychosis 
refers to the first time an individual experiences psychotic symptoms or psychotic 
episode. Approximately three percent of all Canadians will experience a psychotic 
episode in their lifetime (Mheccu, 2000). It usually occurs in late adolescence-early 
adulthood. Symptoms of early psychosis include hallucinations, delusions, bizarre 
behaviours, and mood changes (Mheccu, 2000). Research has found that psychosis is a 
treatable medical condition, but recovery varies from person to person (EPPIC Statewide 
Services, 2000b ). 
Several studies have shown that a delay in treatment and prolonged duration of 
psychosis is correlated with poorer clinical outcomes and major health care expenditures, 
such as increased hospitalizations and expensive medication (McGlashan & Johannessen, 
1996). Detecting psychosis at the earliest possible time can reduce symptoms and 
promote recovery, thereby providing long-term benefits for patients and their families 
(McGorry & Yung, 2003). 
Early psychosis programs have been developed as a solution to reduce delays in 
treatment and improve outcomes. These programs are designed to provide structured 
treatment for three years. McGarry et al. in Melbourne, Australia (2000a); Addington et 
al. in Calgary, Canada (2004a); and Malle et al. (2001) in Ontario, Canada have evaluated 
their programs and have found that these programs do reduce delays and hospitalizations, 
improve patients' quality of life and can help reduce medication dosage. Thus, these 
programs have clinical and economic benefits. The Newfoundland and Labrador Early 
Psychosis Program (NL Program) was established in 2001 and has not yet been evaluated 
to determine if this program provides beneficial treatment outcomes. 
1.2 Purpose of this Study 
The purpose of this study is to evaluate the overall impact of the NL Program for 
patients. 
The difficulty in evaluating a program that is designed specifically for a unique 
population is determining the best methodology to use for the most accurate results. 
While a Randomized Clinical Trial (RCT) is recognized as the gold standard in program 
evaluation, it is not always ethical to randomly assign patients to two groups, i.e. those 
who will receive treatment and have another who will not receive treatment to determine 
a treatment effect. There are ethical challenges to conduct a prospective study in which 
individuals with early psychosis are denied treatment at random for prolonged periods of 
time in order to assess outcome (McGarry, 2000a). RCTs also have high internal validity 
since the intervention is done under controlled circumstances with double-blinded 
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procedures. The difficulty in performing an RCT to evaluate an early psychosis program 
is that there is evaluator and participant bias that can influence the treatment effects. 
Recently, Petersen et al. (2005) performed an RCT of integrated versus standard 
treatment for first-episode psychosis. Patients were randomized into either treatment by 
computer-generated random lists. Both treatments offered the same anti-psychotic 
medication and psychotic care provided routinely by the mental health services, but the 
integrated treatment included more personal contact and follow-up by the 
multidisciplinary team and more support facilities. Their RCT found the integrated 
treatment had a significantly better effect on clinical and social outcomes of patients 
compared with standard treatment (Petersen et al., 2005). This was the first study to 
perform an RCT design on first psychotic patients using integrated versus standard care. 
Other studies have used a methodology of comparing patients to historical control 
groups. However, this methodological approach also has limitations. Simple 
comparisons of individuals receiving different treatments are potentially biased in that 
they do not reveal the effect of treatment per se, and there maybe baseline differences that 
could be an explanation for the observed differences. 
Therefore, most studies to date as outlined in the literature review (Chapter 2), 
evaluated early psychosis programs by assessing patients at entry into the program and 
after completion of the program on several outcomes to determine a treatment effect 
(Addington et al., 2004b; Malia et al., 2001a). However, there may also be a flaw in 
using pre-post methodology. First, there are no standard control groups being used. An 
evaluation of a program by comparing the early psychosis group with a control group 
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would be of value since any differences found between the groups on clinical and social 
outcomes would suggest a treatment effect of the program. Secondly, the researchers 
using a pre-post approach implicitly assume any changes in the patients' outcomes from 
entry to completion of the program are due to the treatment. However, since early 
psychosis patients tend to be young, the treatment affects maybe due to natural events, 
such as maturation and changes in hormones. 
Another evaluation approach, propensity matching, allows matching of a unique 
group to a control group on similar variables, such as gender, age and living status, to 
eliminate baseline differences. Propensity matching is based on a critical assumption that 
individuals who are matched on the same characteristics can then be sorted into treatment 
and control groups as if randomly assigned (Ascher-Svanum et al., 2003). Given the 
assumption of no baseline differences, the groups can then be compared on several 
clinical and social outcomes, such as employment, substance use and hospitalizations, to 
determine ifthe program has helped patients improve from initiation to the end of the 
three-year program. This study is the first time an early psychosis program will be 
evaluated using propensity-matching methodology. 
The objectives of this study are: 
1. To evaluate the impact of the NL Program for patients on a number of 
clinical and social outcomes. 
2. To use propensity matching to match psychosis patients with the 
general population on demographic variables to eliminate baseline 
differences since randomization into the program is not feasible. 
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3. To use a national database, the Canadian Community Health Survey 
(CCHS), as the general population for comparison with the NL early 
psychosis patients. 
4. To determine how the patients differ from the general population at 
entry level into the NL Program on clinical and social variables, such 
as employment and hospitalizations. 
5. To determine if patients at the end ofthe NL Program converge back to 
the population mean on the same variables. 
6. To compare and contrast this new methodology with the traditional 
pre-post methodology, which evaluates the patients before and after in 
a program to determine the treatment effect of early psychosis 
programs. 
The Importance of This Research 
This research will test a novel methodology on a unique population. If 
this methodology does prove to be more useful in evaluating unique population 
programs, then this method may serve as a model for future program evaluations in 
mental health research. According to McGorry ( 1998) evaluation allows clinicians to 
judge the value of an intervention and that outcome data can influence policy makers. 
Good quality evaluation can help protect innovative services in an environment of scarce 
resources. 
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1.3 Structure of the Thesis 
Following this introductory chapter, Chapter 2 provides an introduction to 
psychosis, describing its characteristics, identifying who can develop psychosis, 
examining what can cause psychosis to occur, describing the different types of psychoses, 
the characterizing symptoms and the three phases of the disorder. The chapter continues 
with a literature review of studies completed on early psychosis, such as the effects of 
delayed treatment (duration of untreated psychosis-DUP), the importance of early 
intervention, the development of early psychosis programs as a solution and studies that 
have evaluated the programs and their outcomes. Finally, previous studies using 
propensity matching will be discussed. 
Chapter 3 describes the methodology used to evaluate the NL Early Psychosis 
Program, using the NL Program and the CCHS databases. 
Chapter 4 presents the results obtained using the propensity matching 
methodology and the pre-post methodology. 
Chapter 5 presents a summary and discussion of the results. 
Chapter 6 is the concluding chapter that highlights the importance of the research 
findings, the research limitations and recommendations. 
All the references used in this thesis will be placed at the end. The appendices 
will follow, which includes a letter asking permission of the NL Early Psychosis 
Coordinators to use the patient database; an Early Psychosis Program approval letter 
granting permission to use the database; HIC application; HIC approval letter; RP AC 
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application; RP AC approval letter; and matched questions from the Early Psychosis 
Program scales and the Canadian Community Health Survey (CCHS). 
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CHAPTER2 
LITERATURE REVIEW OF EARLY PSYCHOSIS 
2.1 What is Psychosis? 
Psychosis is a medical condition that affects the brain. It involves loss of contact 
with reality and is characterized by notable changes in a person's thoughts, beliefs, 
perceptions and/or behaviours (EPPIC Statewide Services, 2000a). Approximately three 
percent of all individuals will experience a psychotic episode in their lifetime (Mheccu, 
2000). Eighty percent of episodes usually occur in late adolescence or early adulthood 
(ages 16-30). The median age of first onset of psychosis is 19 years (Mheccu, 2000). 
Adolescence is the stage in life where individuals go though a biological process 
of physical maturation, which closely interacts "with psychological and social tasks of 
preparation for independence and adult responsibilities" (Goudreau, 2003). Many youth 
have difficulty adapting and accepting the change and transformations that occur during 
this time (Goudreau, 2003). Psychosis is a challenging condition to face at any point in 
life, however its effects can be particularly disruptive during this critical period of 
development. It can seriously damage a young person's development of identity and 
interrupt their ability to create and maintain relationships and long-term vocational plans 
to create a meaningful and productive future (Liberman & Fenton, 2000). Thus, it is a 
confusing and disturbing process for both the person and their family. The initial 
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reactions to psychosis can range from bewilderment to denial, anxiety and shock 
(Kuipers & Raune; 2000). 
Research has found that psychosis affects males and females equally. However, 
studies have found females typically experience a first episode two to three years later 
than males (Loebel et al., 1992). It can also occur across all cultures and socioeconomic 
status. McGarry & Killackey (2002) reported that mental health problems account for 
75% of the burden of disease in the late adolescent-early adult group. 
2.2 What Can Cause Psychosis? 
Several theories have been suggested as contributing factors to developing 
psychosis, but there remains no clear consensus as to the underlying cause (EPPIC 
Statewide Services, 2000a). Although the exact causes of psychosis remain unknown, 
evidence supports the fact that psychotic disorders are brain disorders that result from 
disturbances in brain functioning. The "stress-vulnerability" model is one proposed 
theory to understand the onset and course of psychosis (Mheccu, 2000). This model 
suggests that psychotic symptoms can be triggered by interactions between a biological 
predisposition (genetic and neurodevelopmental factors) and environmental stressors 
(Mheccu, 2000). In other words, biological factors create vulnerability to experiencing 
psychotic symptoms, which when coupled with environmental stressors, such as 
substance abuse, psychotic symptoms often emerge in such vulnerable individuals. Some 
factors may be more or less significant in one person than in another. Some biological 
9 
factors include a positive family history of psychosis and paranoid personality disorders 
(Mheccu, 2000). For example, the risk of developing psychosis is 1% for the general 
population compared to 13% for the children who have parents with schizophrenia 
(Mheccu, 2000). Other causes of psychosis include substance abuse or withdrawal; 
social changes; psychiatric disorder; prenatal complications; obstetric complications; 
dopamine dysfunction; neurotransmitters; and/or viruses. 
2.3 Types of Psychosis 
Individual experiences of psychosis and the type of psychosis diagnosed vary. 
Diagnosis means "identification of an illness by a person's symptoms and it will depend 
on the cause ofthe illness and the duration of the symptoms" (EPPIC Statewide Services, 
2000a). There are a number of conditions that can present psychosis such as the 
following: 
• A) Drug-Induced Psychosis: This psychosis occurs from using or 
withdrawing from alcohol and drugs (EPPIC Statewide Services, 2000a). 
• B) Organic Psychosis: Psychotic symptoms appear as a result of a head 
injury or a physical illness, such as AIDS or a tumor, which disrupts brain 
functioning (EPPIC Statewide Services, 2000a). 
• C) Brief Reactive Psychosis: Psychotic symptoms appear as result of a 
sudden response to a major stress in the individual's life, such as a death 
in the family (EPPIC Statewide Services, 2000a). 
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• D) Delusional Disorder: Psychotic symptoms appear as a result of false 
beliefs (EPPIC Statewide Services, 2000a). 
• E) Schizophrenia: There are changes in a person's behaviour that have 
continued longer than six months. (EPPIC Statewide Services, 2000a). 
• F) Schizophreniform Disorder: There are changes in a person's behaviour 
that last less than six months (EPPIC Statewide Services, 2000a). 
• G) Bipolar (Manic-Depressive) Disorder: This psychotic illness is 
characterized by psychotic symptoms following the persons' general 
disturbance in mood, either extreme highs (mania) or lows (depression) 
(EPPIC Statewide Services, 2000a). 
• H) Schizoaffective Disorder: Psychotic symptoms are present that are not 
distinctive of a mood disorder or schizophrenia. The person has 
alternating symptoms of both a mood disorder and psychosis (EPPIC 
Statewide Services, 2000a). 
• I) Psychotic Depression: Illness involves severe depression with 
psychotic symptoms. However, unlike bipolar disorder, there are no 
periods of mania (EPPIC Statewide Services, 2000a). 
2.4 Psychotic Symptoms 
============================================================== 
Symptoms of psychosis develop gradually over a period of weeks, months or even 
years. Symptoms vary from person to person and may change over time. The symptoms 
can be classified into positive, negative and cognitive symptom clusters. 
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Positive symptoms include hallucinations, delusions, thought disorder, 
disorganization, and bizarre behaviour (Kuipers & Raune, 2000). Hallucinations are 
distorted perceptions, such as the individual sees, hears, feels, smells or tastes something 
that is not actually there. Delusions are fixed false beliefs; such as the belief that their 
house is being monitored by police (Kuipers & Raune, 2000). Thought disorder 
symptoms can occur when the individual has jumbled or unusual thought processing, 
such as thoughts seeming to speed up or slow down (Kuipers & Raune, 2000). They may 
find it difficult to express themselves (Mheccu, 2000). Disorganization occurs when the 
individual has difficulty organizing thoughts, speech and/or behaviour. And finally, 
bizarre behaviour occurs when an individual behaves differently from usual (EPPIC 
Statewide Services, 2000a). For example, they may become angry without apparent 
cause, or will stop eating because they are concerned that the food is poisoned (EPPIC 
Statewide Services, 2000a). 
Negative symptoms include emotional unresponsiveness, loss of motivation, 
poverty of speech and social withdrawal (Mhecuu, 2000). Individuals may display 
inappropriate emotional display. Loss of motivation is present when an individual has no 
desire to perform activities, such as homework. Poverty of speech is manifested when it 
is difficult to understand the language used by the individual. Social withdrawal is 
characterized by an individual withdrawing from relationships with family and friends. 
There are also cognitive symptoms associated with psychotic disorder. Cognitive 
problems may include problems with verbal, working and spatial memory, and as well as 
difficulty concentrating and focusing attention (Lieberman & Fenton, 2000). 
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Other symptoms that are additional early signs of psychosis may include: sleep or 
appetite disturbances, agitation, anxiety, depression, suicidal thoughts and impaired role 
functioning, such as not fulfilling the role of a parent (Mhecuu, 2000). 
2.5 Three Phases of Psychosis 
A psychotic episode can be divided into three phases, with the duration of each 
phase varying from person to person. The three phases are the prodromal phase, the 
acute phase and the recovery phase. 
The Prodromal Phase is the period during which the individual experiences 
changes in feelings, thoughts, perceptions and behaviours but they have not experienced 
clear positive psychotic symptoms such as hallucinations, delusions or thought disorder 
(Mheccu, 2000). These prodromal signs are vague and hardly noticeable, and do not 
always precede the acute phase. Some prodromal symptoms include: feelings of vague 
suspiciousness, depression, anxiety and mood swings; difficulty in concentrating and 
remembering; feeling somehow different from others; sleep disturbances; appetite 
changes and loss of energy or motivation (EPPIC Statewide Services 2000c). Family 
members or friends may notice that the individual's behaviour changes, their studies or 
work deteriorate, they become more withdrawn, socialize less or they might become less 
active (EPPIC Statewide Services 2000c). However, these changes could have resulted 
from psychosocial difficulties, physical or psychiatric disorders (Mheccu, 2000). 
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Despite extensive research into the interaction between risk factors and attempts 
to establish developmental pathways of mental disorders, the probability of whether or 
not a particular group of signs and symptoms predicates the development of the disorder 
is unknown (Spencer, 1996). The high-risk research still produces a high level of false 
positives, where individuals who are identified as being at risk due to the presence of 
particular signs, do not go on to develop a full-blown disorder (Spencer, 1996). 
The Acute Phase occurs when the individual experiences clear psychotic 
symptoms, such as hallucinations, delusions or social withdrawal. In order to declare that 
a person is experiencing a psychotic episode, the prodromal symptoms have reached a 
threshold of severity and are persistent. (Lieberman & Fenton, 2000). 
The Recovery Phase occurs when an individual has been identified with psychosis 
and begins treatment. Psychosis is a serious but treatable medical condition, however 
recovery varies from person to person. Research has found that most people do recover 
from a first psychotic episode (Mheccu, 2000). However, others will develop recurring 
episodes of psychosis, but will be relatively well and will continue to lead a productive 
life, especially if they continue on maintenance medication (Mheccu, 2000). The 
recovery process is dynamic, with success being a function of a number of interacting 
factors, such as treatment environment, medication, psychological therapies, families, and 
social environments, all of which will be discussed below. 
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2.6 Consequences ofDelayed Treatment (Duration of Untreated 
Psychosis -DUP) 
Several studies have shown that there is often a significant delay in treatment for 
individuals who experience a first episode of psychosis (McGorry & Killackey (2002); 
McGlashan & Johnannessen (1996); Johnstone, Johnson & MacMillan (1986)). 
Psychosis often remains untreated for many months and some people live with untreated 
psychosis for years. Also, when the illness is recognized, there are often other barriers to 
assessing treatment. Further delays can occur as a result of skill and knowledge gaps 
among professionals. Canadian statistics, on average, indicate that first episode patients 
make 2.3 help seeking contacts following the onset of psychosis; most of these are made 
to emergency services and family physicians (Addington et al., 2002). The duration of 
untreated psychosis (DUP) is defined as "the time from onset of psychosis to the 
initiation of adequate treatment" (Larsen et al., 2000). It has been estimated that DUP 
can be 1-2 years (Kalla et al., 2002). Addington et al. (2002) estimated DUP to be 2-5 
years. These findings suggest that many psychotic patients can be living within the 
society for a considerable period of time with the condition undiagnosed (Kalla et al., 
2002). Delays in identifying and treating psychotic cases represent a major public health 
concern (Kalla et al., 2002). 
Studies have shown that delayed treatment and prolonged duration of delays is 
correlated with poorer outcomes (McGlashan & Johannessen, 1996). Bottlender et al. 
(2003) performed a study involving patients with schizophrenia to test the hypothesis that 
DUP prior to first psychiatric admission adversely affects treatment response and short-
15 
term outcome in schizophrenia. Their results found that a longer DUP was associated 
with lower global functioning and more pronounced psychotic symptoms. They 
concluded that DUP prior to first admission detrimentally affects long-term outcome. 
These researchers stress the importance of health service programs for early detection and 
treatment of patients to reduce DUP and therefore improve patients' outcomes 
(Bottlender et al., 2003). 
Another study by Harrigan et al. (2003) was conducted on first episode subjects to 
test whether DUP predicted 12-month outcome independently of the effects of potential 
cofounders, such as age of onset of symptoms, gender, level of education, severity of 
drug use and diagnosis. The study found that DUP remained a consistent predicator of 
functional and symptom outcome even after controlling for these potential confounders. 
Although the evidence provides supportive, but not conclusive evidence of the 
adverse effects of DUP, DUP should still be the focus of early intervention strategies. 
Reducing delays is justified in order to prevent much unnecessary misery and suffering. 
Undiagnosed and untreated psychosis inflicts a significant burden of suffering and 
confusion for individuals and their families (Lieberman & Fenton, 2000). Untreated 
psychosis is accompanied by impairments in functioning that affect the normal processes 
of development for a young adult (Lieberman & Fenton, 2000). Developmental tasks 
such as building peer and romantic relationships, achieving independence from family, 
acquiring independent living skills, and preparing for future endeavors may all be 
disrupted (Lieberman & Fenton, 2000). McGarry (1998) states that such a prolonged 
delay in treatment during the critical developmental phases of early adult life could 
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negatively influence the capacity for psychosocial recovery, even if the biological 
disturbance could be successfully treated. There is an additional theory that the 
biological change may itself prove less responsive to treatment if it is present for a long 
period before the person is treated with anti-psychotic medication (Wyatt, 1991 ). 
However, there is skepticism of this argument since there are no contemporary RCTs 
comparing timely versus delayed intervention (McGarry, 1998). 
Untreated psychosis also increases high-risk behaviours, such as violence, with 
the impending long-lasting consequences for the individual and/or others (Lieberman & 
Fenton, 2000). DUP also increased rates of relapse (Crow, MacMillan, Johnson, & 
Johnstone, 1986; Addington et al., 2002). Johnstone et al. (1986) found the rate of 
relapse was significantly predicted by delay in treatment, with patients who had a delay 
longer than one year having a greater risk to relapse over the following two years, 
compared to those with a shorter DUP. 
Psychosis accounts for major health care expenditures, such as increased 
hospitalization and treatment with costly medications. Moscarelli et al. (1991) studied 
patients three years after treatment and found the cost of treatment for patients with a 
DUP greater than 6 months was twice the cost of those with DUP less than 6 months. 
Yung et al. (2002) found similar results of the economic burden of a long DUP. 
A summary of the effects of a significant delay in treating psychosis therefore 
includes disruption of life course, parenting role, family and social relationships and 
study or employment. It may also increase family strain: financially if a parent has to 
quit his/her job to become a caregiver of the patient; and emotionally if there are needs 
17 
and expectations of other siblings. As well, it could intensify use of drugs and alcohol; 
increase risk of depression, suicide, criminal activity, hospitalization, economic cost to 
the community, risk of injury to themselves and could lower self-esteem and self-identify 
and slow recovery. Therefore, detecting psychosis at the earliest possible time can reduce 
symptoms and promote recovery, thereby providing long-term benefits for individuals 
and their families. 
2. 7 Reasons for Treatment Delays 
Several reasons have been proposed to explain why there has been a delay in early 
treatment of psychosis. DUP maybe confounded by other predictors of outcomes, such 
as pre-morbid adjustment, family psychiatric history, level of education, homelessness, 
level of substance use and mode of onset (Harrigan et al., 2003). 
Gender can also account for delay in treatment seeking as men have been found to 
have longer DUP than women (Loebel et al., 1992). This may be due to the fact that 
families may have a greater tolerance to the disturbed behaviour in male adolescents or 
that families have a greater difficulty in recognizing psychotic symptoms in males and 
thus delay seeking help for males. McGorry et al. (1996) also reported that longer DUP 
was documented among those living alone compared to those living in a family setting. 
Socio-cultural factors may also affect treatment. Although the early signs are 
universal, the influence of the individual, family, social and health service related factors 
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on treatment seeking behaviour might vary according to different cultural contexts 
(Larsen et al., 2001 ). 
Lack of insight and understanding about mental illness may also delay treatment. 
The individuals experiencing psychosis may not perceive themselves as ill. The initial 
episode of psychosis is often a particularly confusing and traumatic experience for both 
the individual and their family. The change in the individual's behaviour causes concern 
and distress because it is difficult to understand what is happening. This lack of 
awareness and inability to recognize the symptoms of psychosis often leads to delays in 
seeking help, and therefore leave these illnesses unrecognized and untreated. 
Even when help is sought, further delays may occur before the right diagnosis is 
made because recognition of these disorders can be difficult. This can cause problems in 
referral pathways or access to psychiatric services (Kalla et al., 2001). There is often a 
lack of adequate training for community health staff. There can be problems with lack 
of community resourced services or limited access to these appropriate services. 
Sometimes, if services are not available, psychotic individuals are often forced to make 
multiple contacts to find treatment help (Addington et al., 2002). 
Initiation of treatment seeking may be negatively affected by fear ofbeing 
admitted to a psychiatric facility. Etheridge, Yarrow & Peet (2004) found hospital 
admissions to a general acute psychiatric ward for first episode treatment was 
inappropriate because of the adverse psychological effects of young people being placed 
on psychiatric wards with adults. 
19 
Individuals may also have a perception that psychosis is a disability that carries 
with it a "life sentence". They often develop a subsequent anxiety regarding the 
possibility of developing a disorder. They may also believe in the "wait and see" 
approach, denying that there is a problem or thinking that it perhaps can get better on its 
own. Early detection and appropriate treatment offer the best chance for full recovery 
(EPPIC Statewide Services (2000b ). 
One of the major impacts of delay and powerful disincentives to treating 
psychosis is the social fear and stigma associated with mental illness. Individuals do not 
want to become "labeled" in any negative way and therefore be stigmatized and treated 
differently by others. Rosenfield (1997) noted negative effects of the stigma attached to 
mental illness on the psychological well being on the individual. 
2.8 What is Early Intervention? 
Early intervention is a "process of screening, case identification and the provision 
of effective and intensive treatment" (Rickwood, 2000). The interventions are not merely 
the translation of standard treatments developed for later stages of the disorder and for 
more persistent courses of the disorder (McGorry et al., 1996). 
Early intervention can be defined has having 3 components: (1) prepsychotic 
intervention, (2) early case detection and initial treatment, and (3) optimal management 
of the first episode and the subsequent "critical period". These are described below. 
Prepsychotic intervention is the process of identifying people before they have 
become acutely ill. Prepsychotic is thus, primary prevention, which consists of 
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prevention strategies aimed at the total population, such as immunizations (Larsen et al. 
2001). However, identifying early psychosis is very difficult, and there are a substantial 
number ofhigh false positives (Warner, 2001). As well, intervening pharmacologically 
during this period cannot be justified since it is unethical to introduce this treatment given 
the high rates of adverse side effects (Bebbington, 2000). McGarry & Killackey (2002) 
argued that primary prevention is beyond the capacity of our present knowledge. 
As described above, the second component-early case detection-which reduces 
DUP is advantageous to the long-term clinical outcome. Intervention at the onset of 
psychosis prevents chroncity and thus is a form of secondary prevention (Whitehorn, 
Lazier, Kopala, 1998). McGarry & Killackey (2002) state that mental health services 
along with communities, primary care and clinicians should embark upon a range of 
strategies to reduce delays in treatment onset, such as improved recognition skills among 
general practitioners though training, and improved access to mental health services. This 
would substantially reduce DUP and thus, reduce the need for inpatient care and 
involuntary treatment. 
The third component is that optimal treatment in the early phase of psychosis 
could reduce the length of the illness and thus reduce the prevalence of the disorder 
(McGarry & Killackey, 2002). Therefore, optimal treatment should have a positive 
effect over the long-term. Treating young people during this "critical period" is both 
clinically and cost-effective (McGarry & Killackey, 2002; Malia & Norman, 2002). 
The first three years of psychosis (treated and untreated) illness offers an 
opportunity to prevent, or limit, this potential decline (Birchwood, 2000). Jackson & 
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Birchwood (1996) state that there are two main reasons why intervening in the first three 
years may have long-term benefits. First, treating in these early years can predict later 
outcome. Second, social theorists have stated that establishing or reestablishing a range 
of valued roles and goals such as employment would be best done as early as possible 
and cognitive theorists have stated that damage to cognitions also form in the early years. 
Early intervention is hardly an unlikely goal and would be non-controversial in 
other areas of healthcare, where primary prevention remains out of reach, e.g. diabetes, 
and many cancers (Malla & Norman, 2002). It is a strategy that can provide 
considerable long-term benefits. 
2.9 Benefits of Early Intervention 
There are several reasons for early intervention: 
• First, it promotes recovery from the first psychotic episode (McGorry & 
Yung, 2003). Treatment can reduce symptoms. Following a first 
psychotic episode, the probability of recovery is very high (80% ). 
McGorry & Yung (2003) state a first episode of psychosis should be 
viewed as a psychiatric emergency and treatment should be made a matter 
of urgency. 
• Second, the longer the time spent in psychosis the greater the risk of long-
term morbidity. The onset of psychosis is associated with a range of 
comorbidity, such as substance use, depression, suicide and social anxiety, 
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which if successfully addressed, should reduce mortality (McGorry & 
Yung (2003). 
• Thirdly, psychosocial damage can occur in this critical period, such as the 
substantial impact of onset on self-identity and transitions of family life 
(McGorry & Yung, 2003). Early intervention may increase the chances of 
recovery in these areas, thereby improving capacity to maintain self-
identity and self-esteem. 
• Fourth, early intervention may prevent some biological toxicity from the 
brain illness. Treatment can slow the process of deterioration. If 
deterioration does occur early in the course of schizophrenia, earlier 
application of biological or psychological treatments or both should make 
a difference in the long-term course and outcome of the disorder than later 
interventions (McGlashan & Johannessen, 1996). 
• Fifth, it has been suggested that strong investment in early intervention 
will be cost-effective (McGorry & Yung, 2003; Kuipers & Raune, 2000). 
• And finally, it has been suggested that early intervention might be 
beneficial for families and care-givers in reducing depression, stress and 
distress and therefore, the likelihood of these symptoms recurring in the 
individuals (Kuipers & Raune, 2000). Providing therapeutic support that 
emphasizes the importance of improving the quality of relationships can 
help patients to recover. 
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In summary, the focus of early intervention is designed to limit damage to 
personal identity, social networks, and role-functioning and decrease health costs caused 
by the underlying illness (McGorry et al., 1996). 
2.10 Barriers to Early Intervention 
McGorry & Killackey (2002) state that despite the early intervention reform, the 
quality ofhealthcare for those experiencing psychosis remains unacceptably poor. They 
state several reasons: there are considerable pessimistic doubts about outcome; psychiatry 
seemingly has low priority in the healthcare system and as a result is often under funded 
with poor workforce quality; and the advances made in treatment are not always 
translated into clinical settings (McGorry & Killackey, 2002). 
The main problem in justifying early intervention is that randomized controlled 
trials of early intervention cannot be done because of ethical restrictions. (Bebbington, 
2000). This would be an RCT of early and later intervention. However, there are ethical 
challenges to deny early treatment for prolonged periods of time that may be ofbenefit to 
someone (McGarry, 2000a). Harrigan et al. (2003) examined whether the duration of 
untreated illness (DUP) had an affect on patients' outcomes. They found that although 
there was an association between DUP and outcome, they could only provide supportive, 
but not conclusive evidence since their study was only correlational. The casual link 
between prolonged DUP and poor outcomes can only be finally established by 
experimentation. However, some authors argue that since a casual relationship between 
DUP and outcome has not been established, then DUP cannot conclusively be said to 
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relate to poorer outcomes (Kuipers et al., 1994; Verdoux, 2001). Verdoux (2001) 
believes there are other factors delaying treatment seeking that may independently predict 
poor outcomes. V erdoux argues that it is difficult to say that early intervention programs 
benefit individuals because these subjects may differ from those who did not take part in 
the program, for example in terms of illness severity, or in social adjustment and social 
networks. As well, if it is difficult to predict which subjects presenting psychotic 
symptoms will develop a full-blown psychotic disorder in subsequent years, then how 
can it be determined which subject would benefit from early treatment? He also makes 
the point that only a few randomized controlled trials have been performed on first 
episode subjects. Verdoux (200 1) argues that early intervention using psychotherapy is 
not equivalent to early anti-psychotic treatment, implying psychotherapy treatment has 
greater negative consequences compared to those induced by anti-psychotic medication. 
As well, V erdoux (200 1) states that the stigma associated with a mental illness could 
have a major impact of distress for the subject and family. He concludes that the time has 
not yet come to be overconfident in the feasibility and benefits of early intervention 
programs. 
However, as stated earlier, several researchers, such as McGorry et al. (1996) and 
Harrigan et al. (2003), oppose Verdoux's view, stating that early intervention is very 
beneficial for individuals with psychotic disorders by treating symptoms early and 
effectively improving functioning. They state that traditional treatment of patients was 
both crude and insensitive in the way they were delivered to young people during their 
first contact with psychiatric services. In addition, there were significant gaps in 
25 
expertise and resources (McGorry, 1992). The experience ofpsychosis, pathways to care 
that involve the police and/or emergency departments and hospitalization on a secure 
ward are likely to be traumatizing for first time patients and may lead to persisting 
symptoms of post-traumatic stress disorder (Drury, 2000). 
2.11 Early Psychosis Programs 
There are an increasingly large number of groups that have now established 
clinical programs worldwide (Edwards & McGorry, 2002). These early psychosis 
programs are "a comprehensive individualized treatment plan that uses an 
interdisciplinary team approach and incorporates the use of low dose anti-psychotic 
medications with education and psychosocial interventions to promote full recovery from 
early psychosis" (Canadian Mental Health Association, 2002). The programs provide 
dedicated support to all first episode cases for the first two or three years following 
diagnosis (Jackson & Birchwood, 1996). Whitehorn et al. (1998) state that the treatment 
programs reduce the severity ofthe illness by detecting cases early and by providing 
treatment and support, therefore reducing long-term psychiatric disability. It is hoped 
that early psychosis programs, by providing secondary prevention, will help patients as 
they attempt to recover and rehabilitate (Whitehorn et al., 1998). 
There are four elements of management of first episode patients in a program 
(McGorry & Killlackey, 2002). The first element is access and engagement of patients. 
The program should be non-stigmatizing and should identify first episode patients as 
soon as possible to reduce the length of untreated psychosis (DUP) (Addington et al., 
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2002; Kalla et al., 2002). The second element is assessment, which is detecting and 
diagnosing psychosis (McGorry & Killackey, 2002). The third is acute treatment, which 
is integrated care using biological, psychosocial, family therapies, and the fourth element 
is the recovery phase (McGorry & Killackey, 2002). The role of the clinician throughout 
the process is to identify the early warning signs of psychosis, provide a range of 
appropriate and timely interventions and coordinate patient care (Mheccu, 2000). Some 
patients will require hospital admission for treatment or adequate assessment. It is 
important that transport to hospital and the admission itself are also handled with care to 
prevent shame and unnecessary distress (Mheccu, 2000). It has been well documented 
that psychological adaptation and adjustment can be a very difficult and painful period. 
Patients may be traumatized by being admitted to the hospital and/or the involvement of 
the police (Mheccu, 2000). 
Most early psychosis programs are an integration of biological, psychosocial and 
structural elements of intervention which includes novel medication strategies, case 
management, family work, psychoeducation, psychotherapy (individual and group), 
occupational therapy, recreational therapy, spiritual counseling and substance abuse 
counseling (McGorry & Killackey, 2002), all of which will be discussed below. 
Novel medication strategies involve using low doses of medication to minimize 
side effects. The ability of these antipsychotic drugs to reduce symptoms and possibly to 
improve functioning has a major impact in helping patients to participate fully in 
recovery and rehabilitation activities (Whitehorn et al., 1998). 
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Case managers are nurses who coordinate care among a variety of treating 
professionals and create links to other community services, such as social workers and 
occupational therapy services, as needed, to ensure continuity of care for patients 
(Mheccu, 2000). They help normalize the patients' environment as quickly as possible, 
monitor the clinical progress and help them work through recovery. They also provide 
support to family (Whitehorn et al., 1998). 
Family work involves helping families cope, care and understand a loved one 
with a psychotic illness. Involving family should not be under-emphasized. An educated 
and committed family is a valuable resource for the patient and the treatment team. By 
providing the family with information about the illness and the rationale of the program, 
the family will hopefully be able to understand and support the program, and help play a 
role in engaging the patient in the therapeutic process. (Drury, 2000; Whitehorn et al., 
1998). Jackson & Birchwood (1996) found patients with no family contacts tended to 
relapse earlier, have poorer outcomes and poorer occupational functioning. 
Psychoeducation is a method used to train patients about mental illness while 
maintaining an ongoing, interactive psychotherapeutic relationship (Mheccu, 2000). It 
involves personal meaning, mastery and self-esteem. Personal meaning is seeing the 
psychotic disorder as it is related to other life experiences. Patients are taught that 
psychosis has added to their life experience and will be a source of future personal 
information about them, as opposed to erasing the experience from their mind (Jackson & 
Iqbalt, 2000; Whitehorn et al., 1998). They must also realize that psychosis is something 
that is potentially controllable and for which they must take some responsibility to 
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prevent relapses (Jackson & Iqbalt, 2000). Mastery "involves instilling hope for recovery, 
building stress management and coping skills, learning to recognize possible signs of 
relapse and how to access necessary resources in the future" (Mheccu, 2000). Self-
esteem enhancement includes helping patients overcome stigmizing views (i.e. 
incompetence) they may have internalized (Mheccu, 2000; Jackson & Birchwood, 1996). 
Information seeking about psychosis should be encouraged. Staff should provide 
psychoeducation information and an interactive environment in which that can process 
the information. 
Psychotherapy is provided both individually and in-group settings. Group therapy 
provides peer support by sharing of experiences; education; problem-solving 
opportunities for coping skills; and learning to manage through discussion and 
observation, which help to reduce the patient's sense of isolation and bewilderment and 
encourage the person to take on an active social role during a time when psychosocial 
functioning may be low (Mheccu, 2000; Drury, 2000). Albiston, Francey & Harrigan 
(1998) evaluated the impact of a group-based psychosocial program within The Early 
Psychosis Prevention and Intervention Centre (EPPIC), a treatment service in Australia. 
They found the role of group involvement in helping patients to limit the effects of 
psychosis to be significant. They state that further studies are needed to replicate their 
findings and to identify those aspects of group interventions that have the greatest impact 
in promoting recovery and preventing disability in the critical period of psychosis 
(Albiston et al., 1998). 
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Occupational therapy offers patients help in recovery by encouraging and helping 
them complete or continue their education and to integrate them into the workforce. 
Looking for employment can be frightening and overwhelming for people with psychosis 
and may require cooperation between mental health, social services and employment 
agencies to facilitate the pathway and to prevent relapse (Jackson & Birchwood, 1996). 
Recreational therapy provides social activities. It has been well documented that 
social isolation is an occurring factor with psychosis and its effects can be long-term 
(Jackson & Birchwood, 1996). Therefore, community-oriented care involving assertive 
outreach can improve quality and quantity of social networks (Jackson & Birchwood, 
1996). 
Other forms of non-pharmacological interventions include stress management 
approaches and cognitive therapy. Stress management approaches "help people develop 
coping strategies and reduce vulnerability to stress-induced relapse" (Mheccu, 2000). It 
shows patients ways to deal with their stress, recognize potential relapse symptoms and 
modify the stressor by adjusting their environment or behaviour (Mheccu, 2000). 
Cognitive therapy is a "structured psychotherapy directed toward solving current 
problems by modifying distorted thinking and behaviour" (Mheccu, 2000). Cognitive 
behaviour therapy may be used to treat non-psychotic symptoms such as depression, 
anxiety, and substance abuse and is increasingly recognized in treating the positive 
symptoms of psychosis (Mheccu, 2000, p203). 
The cognitive aspects of the group work focuses on "individual's beliefs about the 
origins and maintenance of their psychotic symptoms, assessing the loss and reduced 
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control associated with developing a psychosis, subjective assessment of risk and benefits 
of treatment in context of personal goals and values and the negative thoughts and beliefs 
about stressors and anxiety-provoking situations" (Drury, 2000). The Drury et al. ( 1996) 
study used Cognitive Behavioural Therapy (CBT) for one group compared to a group 
receiving standard care. The CBT group led to 25-50% reduction in recovery time and a 
50% reduction in time spent in hospital. However, Haddock et al. (1999) evaluated the 
effectiveness of individual cognitive-behavioural therapy in early psychosis and found no 
significant difference between those who received CBT and those who received standard 
psycohoeducational therapy. Jackson et al. (2001) and Ueland & Rund (2004) found 
similar results to Haddock et al. (1999). 
Gorrell et al. (2004) evaluated an early psychosis service offered to young 
patients experiencing psychosis with the introduction of specialized early psychosis 
teams and staff training and compared them to those who received treatment prior to the 
service being implemented. They used 24 clinical indicators to measure optimal care 
over a 12 month period. Their results indicated significant improvements in service 
provision for 10 indicators, such as family involvement, case manager involvement, 
change in medication regime and psychological aspects of a biopsychosocial approach, 
suggesting there has been substantial progress in early psychosis programs. 
A focus group consisting of first episode patients described their experiences in 
the Southwark First Onset Psychosis Service (FIRST) in O'Toole et al. (2004) study. 
Participants identified several key elements that helped them in their recovery, including 
the 'human' approach which consisted of individualized care, time and attention and 
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partnerships; being involved in treatment decisions; flexibility of service delivery and 
appointment times; reduction in psychotic symptoms; increased confidence and 
independence; and provision of daily structure. This was the first qualitative evaluation 
of users' experiences. The authors concluded by stating what is considered important by 
mental health researchers and clinicians might be different from those expressed by 
patients. Focus groups ensure priority is given to the respondents 'hierarchy of 
importance' (O'Toole et al., 2004). 
Yung et al. (2003) evaluated the management of early psychosis patients at a 
hospital for general adults and compared them to the published data ofEPPIC service that 
only focuses on treatment for first-episode patients. Subjects were compared on the 
number of required admissions, average length of stay, DUP, psychotic drug dosage and 
if police were involved if there was an involuntary admission. The study found police 
involvement, length of stay and DUP were lower for EPPIC patients. Furthermore, 
general adult mental health services tended to focus on the needs of the majority of 
patients (ie. those with chronic schizophrenia). Patients may also be exposed to high 
levels of potentially traumatizing events such as a closed environment with large numbers 
of older and chronic patients. As well, staff may not be aware of the needs of this group, 
who are dealing with a psychotic episode for the first time. Most staff has dealt with 
patients who are familiar to the system. Thus, early psychosis programs are important in 
reaching the young person and providing services directed to their needs. 
Addington, Leriger & Addington (2004a) undertook a study to determine the 
change in positive, negative and depressive symptoms in the Calgary Early Psychosis 
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Program. Subjects were assessed every three months up to the first year. Symptoms 
were measured using the Positive and Negative Syndrome Scale (P ANSS) and the 
Calgary Depression Rating Scale for Schizophrenia (CDSS). Their study found 
significant improvements in positive symptoms by three months; depressed symptoms by 
12 months and negative symptoms changed little. Thus, early psychosis programs helps 
individuals improve over time, but their needs to be more emphasis on early detection of 
negative symptoms since they may be well established prior to entry into treatment. 
Mihalopoulos, McGorry & Carter (1999) conducted an evaluation at the EPPIC 
program in Australia to examine its cost-effectiveness in terms of improving outcomes 
for young people experiencing psychosis and providing 'value for money'. EPPIC 
patients were compared to Pre-EPPIC patients on a number of symptomatic and 
functional outcomes over 1 year as well as a cost-effective appraisal were undertaken. 
For example, the cost of improvement in psychosocial functioning was measured by the 
Quality of Life Scale and the resource utilization for each subject. Their study found the 
EPPIC model to be more cost-effective since it achieved better treatment outcomes and 
saved resources through the reduction in in-patient bed days. They concluded, that 
although community based care is expensive, it was approximately half the cost of in-
patient utilization that was incurred when community based care was not available. They 
concluded that reducing the provision of inpatient care without such enhancement of 
community care would substantially worsen outcomes for patients. Thus, the shift of 
resources from hospital to community represents an economically viable method of 
improving patient outcomes. Rappaport (1989) used a similar cost-effectiveness index 
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(CEI) as a tool to help evaluate mental health programs. Yung et al. (2003) also reported 
the economic burden of hospitalization, which makes up 50-90% of direct treatment 
costs. 
Thus, early psychosis programs are seemingly cost-effective, reduce symptoms, 
maximize the chances of full recovery and minimize the likelihood of relapse and 
comorbidity. 
2.12 Current Models of Early Intervention 
Australia 
The Early Psychosis Prevention and Intervention Centre (EPPIC) was developed 
in Melbourne, Australia in October, 1992 by a group of clinicians and researchers, to 
provide early detection and optimum treatment for first psychotic episode patients 
(Larsen et al., 2001; McGarry, 1996). It has a 24-hour mobile assessment and 
community treatment team, The Youth Access Team (Y AT), which is the first point of 
contact with EPPIC (Edwards et al., 2000). The Personal Assessment and Crisis 
Evaluation (PACE) clinic was also established to identify and treat individuals who are 
thought to be at risk of developing a psychotic disorder (Edwards et al., 2000). EPPIC 
has outpatient case management and medical treatment for early psychosis patients. The 
center has a 16-bed inpatient service to help reduce the symptoms (Edwards et al., 2000). 
In addition to using low dosage of psychotic drugs, the group program provides acute and 
recovery groups for four themes: vocation, creative expression, recreational, and personal 
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development (Albiston et al., 1999). There are family sessions to provide support and 
education about psychosis (Albiston et al., 1999). There is also a focus on suicide 
prevention. Finally, cognitive oriented psychotherapy for early psychosis (COPE) is 
offered to help patients understand the illness and its effects on their self-concepts and 
self-esteem (McGorry, 1996). An evaluation ofthe EPPIC program was done by 
comparing EPPIC patients with patients treated prior to the development of the EPPIC 
program. The non-EPPIC group was considered the control group and had previously 
been assessed over one year. The EPPIC group was also followed and assessed over one 
year. Thus, both groups were analyzed using the pre-post methodology and then the 
EPPIC group was compared to the non-EPPIC group. The overall evaluation found that 
there were improvements in quality of life, including social and role functioning, for 
EPPIC patients resulting from them receiving a treatment package combining intensive 
case management, psychosocial interventions, family support and education, and low-
dose medication strategies (McGorry et al., 1996; Edwards et al., 2000; Larsen et al., 
2001). These results were strongest for patients with a DUP of 1-6 months, which is a 
short treatment delay (Larsen et al., 2001 ). The level of post-traumatic stress, previously 
associated with hospitalization, was reduced and the length of average stay and drug 
dosage was reduced (Edwards et al., 2000). 
Europe 
An Initiative to Reduce the Impact of Schizophrenia (IRIS) was developed in the 
UK by the West Midlands Early Psychosis Group to pursue positive outcomes for young 
psychotic patients and their families (Edwards et al., 2000; Macmillan & Shiers, 2000). 
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IRIS produced a framework of standards of care that had a set of core principles, which 
included "a youth and user focus; the importance of early and assertive engagement; the 
embracing of diagnostic uncertainty; treatment to be provided in the least restrictive and 
stigmatizing setting; an emphasis on social roles and a family-oriented approach" 
(Macmillan & Shier, 2000). 
Larsen et al. (2000), in Norway and Denmark, developed an educational 
campaign called TIPS to investigate whether early identification of first episode 
psychosis leads to better long-term outcomes. First episode patients at three different 
sites were compared, with TIPS being aimed at only one group and the remaining two 
groups acting as controls (Edwards et al., 2000). The TIPS campaign included public 
lectures on selective psychiatric topics, newspaper advertisements, information 
brochures, and movies with panel discussions. All three groups did receive the same care 
of clinical and psychotherapy treatments. Evaluation occurred at baseline, 3 months and 
one, two and five years. Their study found that the group at which the information 
campaigns were aimed (GPs, family, schools and patients themselves) was more 
successful in helping them detect patients earlier. Melle et al. (2004) published similar 
results that early detection programs significantly shorten DUP compared to patients in 
no early detection areas. 
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Canada - Early psychosis programs have emerged in Canada in the last seven years. 
Although there are programs developed throughout the Country, this thesis will only 
discuss four Canadian early psychosis programs. 
Whitehorn, Lazier & Kopala (1998) developed a comprehensive program in Nova 
Scotia that provides support to individuals by identifying their goals and helping them 
overcome obstacles encountered in returning to school, work and social settings 
(Whitehorn et al., 1998; Edwards et al., 2000). A psychiatrist sees each patient as often 
as necessary. In the initial medication adjustments, a psychiatrist sees each patient 
weekly or biweekly and then less often. They prefer to use "the term 'medical condition' 
rather than 'illness' since a medical condition is one that is associated with biological 
alternations and is improved by drug therapy and other treatments" (Whitehorn et al., 
1998). They state that recovery of social and occupational functioning requires a longer 
period of time than symptom reduction. An overall evaluation of the program using pre-
post methodology found that most families reported that the patient improved functioning 
and were able to continue pursuing their education after 2 years, and those over the age 
27 have been able to return to some degree of social and occupational independence 
(Whitehorn et al., 1998). 
Early Psychosis Treatment and Prevention Centre in Calgary, Alberta offers 
comprehensive services to first episode patients for a three-year period (Addington et al., 
2002; Addington et al., 2004b; Edwards et al., 2000). The program includes outpatient 
case management, which involves psychiatrist and case manager assignment who 
undertake assessment and monitoring functions as well as provide assistance in 
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contacting agencies for employment or housing. The program includes psychotherapy, 
psychoeducation, and individual cognitive therapy to help patients adapt to the psychotic 
illness and the effects on life circumstances (Edwards et al., 2000). Patients are taught 
skills to manage anger and stress and are provided with substance use and suicidal 
prevention counseling (Edwards et al., 2000). One of the components ofthe program is 
family intervention. There is individual family work with education about psychosis and 
strategies for coping with the disorder, as well as family group work and communication 
training. The program also offers education to mental health agencies, family physicians, 
and school and colleges about psychosis, how to recognize the signs and how to access 
treatment. An overall evaluation of the program using pre-post methodology found that 
symptoms were reduced and there was medication adherence to low dose atypical drug 
therapies. Furthermore, there were improvements in insight and social outcomes and 
reduction in suicidal thoughts and substance use (Addington et al., 2003; Addington et 
al., 2004a; Addington et al., 2004b; Edwards et al., 2000). 
The Prevention and Early Intervention Program for Psychosis (PEPP) established 
in 1997 in London, Ontario is a community-oriented, comprehensive, multidisciplinary 
assessment, treatment and research program (Edwards et al., 2000, Malla et al., 2003; 
Scholten et al., 2003). The program consists oftwo essential components: (1) early 
detection and (2) medical and psychosocial assessment and treatment to reduce DUP 
(Malla et al., 2003). It utilizes an assertive case management model, whereby the case 
manager's role includes assessment, treatment and helping the patient with recovery. 
(Edwards et al., 2000; Malla et al., 2003). "This is achieved through a close partnership 
38 
with families, strong therapeutic relationship with the patient, community services, 
educational institutions and employers to reintegrate the young person to his/her full 
potential over a 2-year period" (Malla et al., 2003). Some patients are given extended 
case management for additional one to three years if they are not sufficiently recovered to 
assume independent functioning (Malta et al., 2003). All patients continue with medical 
management for at least five years. (Malta et al., 2003). An eight-week group 
intervention addresses issues of stigma, identity, peer pressure, and substance use as well 
as provides skills training (Edwards et al., 2000). It also has a 16-bed inpatient unit 
(Edwards et al., 2000). An overall evaluation of the program, using both pre-post 
methodology by following the patients over one year and then comparing to a historical 
control group prior to the establishment of PEPP, found the use of low drug dosage, high 
retention and remission (75%) rates, and significant improvements for self-rated quality 
oflife and cognition, and DUP and symptoms reduction (Malia et al., 2003). 
The Newfoundland and Labrador Early Psychosis Program (NL Program) was 
established in the Winter 2001. The goals of the NL Program include promoting early 
recognition of psychosis and reducing DUP; providing optimum, safe and comprehensive 
assessments, intervention and support for patients and their families; and promoting 
recovery and preventing relapse. Other goals include promotion of education on 
psychosis to primary care physicians, mental health professionals and community 
resources; and continuing research in the area of early psychosis. The NL Program 
involves three years of comprehensive individualized treatment that includes the 
following components: psychiatric care, case management, low-dose medication regimes, 
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family intervention, psychotherapy (individual and group), occupational therapy, 
recreational therapy, spiritual counselling, substance use counselling and research. 
Individuals referred to the NL Program are experiencing a psychotic episode for the first 
time. At initiation to the NL Program, a full assessment of the patient by a psychiatrist is 
carried out by a structured clinical interview to confirm diagnosis of a psychotic disorder. 
Following admission to the NL Program, the assigned psychiatrist sees each patient as 
often as necessary, with weekly or biweekly visitations in the beginning for medication 
adjustments. The NL Program has not yet been evaluated since the first patients are only 
now finishing or have completed their third year of treatment. 
Evaluations of the programs 
Evaluations of the early psychosis programs in Australia and Canada have found 
that the interventions can help reduce DUP, lower medication dosage, increase 
medication adherence, reduce hospitalization, improve quality of life, improve insight, 
foster and maintain family and social support, and reduce the secondary effects of 
psychosis, such as social and educational disruption and substance abuse (McGarry et al., 
1996; Whitehorn et al., 1998; Mall a et al., 2003; Addington et al., 2002). Evaluations of 
some of these outcomes will be discussed further below. 
Insight 
"Insight can be defined as "a patient's awareness of having a mental disorder, of 
the social consequences of the disorder, and of the need for treatment" (Mintz, Addington 
& Addington, 2004). Earlier studies on insight have suggested that 50-80% of patients 
do not think they have a psychotic illness (Mintz et al., 2004). Mintz, et al. (2004) 
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conducted a study to determine if insight improved after one year of treatment in their 
Calgary early psychosis program. They assessed the patients' insight over one year using 
the P ANSS scale, using the lack of judgement and insight variable. They found insight 
did improve over the one year as positive symptoms improved, especially in the first 
three months after treatment began. This program offered patients cognitive-behavioural 
and other psychosocial interventions that may have helped to improve their knowledge 
and understanding of the illness, and thus may have impacted their level of insight. 
Hospitalization 
Whitehorn, Richard & Kopala (2004) determined the rates of hospitalization 
during the first year of treatment for schizophrenia in Nova Scotia. Their study found 
patients who were initially diagnosed while inpatients had a higher rate of hospitalization 
in the first year of treatment compared with those initially diagnosed while outpatients. 
They also found hospitalization rates were higher for those who lived in rural areas. 
Thus, emphasis should be placed on preventing hospitalization during the first year. 
Medication Adherence 
A major problem in treating psychosis is non-adherence with medication 
(Coldham, Addington & Addington, 2002; Bebbington, 2000; Bryden et al., 2003). 
Coldham et al. (2002) reported that numerous studies have found 40% of patients 
stopping medication within one year and 75% by two years, thus having a significant 
impact on the illness, with social and psychological consequences, as well as increasing 
relapse, hospitalization and poorer outcomes. Coldham et al. (2002) stated that it is 
important to address the adherence of first episode patients since the younger patients are 
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more likely to be non-adherent than older patients. The major reason for non-adherence 
is that the drugs have many adverse side effects (Bebbington, 2000). However, if it is 
possible to reduce the dosage for effective treatment and therefore, improve the 
experience of medication, then this increases the likelihood of adherence (Bebbington, 
2000). The development of newer antipscyhotic atypical drugs is designed to minimize 
the side effects (Bebbington, 2000). There is increasing evidence that these novel 
anti psychotics are recommended over the conventional agents because of their safety 
profiles and their effects on positive and negative symptoms (Currier, 2000). They are 
also better tolerated than conventional treatments and therefore increase patient 
compliance (Bryden, et al., 2003). However, these newer drugs are also very expensive 
(Bebbington, 2000). A one year study looking at pharmacy refill records of patients 
treated with typical versus atypical drugs found moderately higher adherence rates in 
those treated with the atypical drugs (Bryden et al., 2003). Therefore, since these newer 
drugs increase patient adherence, the higher costs of these drugs are relatively minor 
compared to the higher costs ofhospitalizations.(Bebbington, 2000; Fuller, Shermeck, 
Secic, Laich, Durken, 2002; Bryden et al., 2003). Fuller et al. (2002) compared the costs 
between patients taking typical drugs versus atypical drugs. They found that those taking 
atypical drugs had higher drug costs but lower hospitalization costs and therefore, overall 
all, their total costs were lower than patients using typical drugs. 
Coldham et al. (2002) conducted a study to determine the rates of medication 
adherence in first episode patients in their early psychosis program in Calgary. They 
defined "non-adherence as dropping out of the program before one year and/or took 
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medication erratically or not at all". Inadequate adherence was defined as "taking 
medication irregularly", and finally, good adherence was defined as "rarely or never 
missing a dose of medication". Their results found 39% non-adherent, 20% inadequate 
adherent and 41% good adherent. The non-adherent patients were younger, had an early 
age of onset, were less likely to have family contact and demonstrated more positive 
symptoms, more relapses, more substance use, reduced insight and poorer quality of life. 
They conclude that relationships with family members are important to be maintained as 
well as interventions for substance use. Bebbington (2002) suggests that the experience 
of medication can be enhanced in non-pharmacological ways, such as building a trusting 
mutual relationship with patients and providing them with information in an amount, 
sequence and manner that makes them feel safe, valued and involved. 
Substance Use 
Psychiatric comorbidities in psychotic disorders are often under-recognized, 
under-diagnosed and under-treated. It is, therefore, important for clinicians to recognize 
and diagnose them early in the course of the psychotic illness and administer appropriate 
treatment when necessary (Sim et al., 2004). It has been estimated that 60% of 
individuals suffering from schizophrenia use illicit drugs and alcohol (Addington & 
Addington, 2001). Those who use the substances say that they help to relieve a variety of 
unpleasant non-psychotic experiences, and it decreases depression, anxiety and the side 
effects of antipsychotic medication (Addington & Addington, 2001 ). Substances are 
damaging to a psychotic patient because they may increase positive symptoms, and thus, 
may cause damage to an already compromised brain (Addington & Addington, 2001). 
43 
Studies have found a higher prevalence of substance abuse in first episode samples 
(Hambrecht & Hafner, 1996), and past substance abusers had a significantly younger age 
of onset than the non-abusers (Van Mastrigt, Addington & Addington, 2004). Van 
Mastrigt et al. (2004) examined the prevalence and correlates of substance misuse in first 
episode patients at the time they received their first treatment. The Case Manager Rating 
Scale for Substance Use Disorder was used to assess the level of substance use over the 
past year. Their study found substance misuse was higher amongst patients compared to 
the general population and was significantly higher among males, younger patients and 
the younger the age of onset (Van Mastrigt et al., 2004). Pencer & Addington (2003) 
also stated that problems with substance use for psychotic patients include greater 
severity of symptoms and poorer prognosis, significantly more admissions to hospitals 
and outpatient visits, higher medication dose and medication nonadherence. Van 
Mastrigt et al. (2004) concluded that the extent of substance misuse in the first episode 
group should be addressed as part of an integrated treatment program since it has clinical 
implications for treatment. 
To address the problem of substance abuse among first episode patients, the 
Calgary Early Psychosis Treatment and Prevention Program offered several substance 
abuse treatment strategies within the psychosocial treatments offered (Addington & 
Addington, 2001). As well, a Stopping Substances Group was formed at the end of the 
first year of treatment to help educate, engage, and support patients with substance use 
problems. The group discusses issues such as how to resist peer pressure; avoiding risky 
situations and learning new skills to cope with daily living once they become abstinent 
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(Addington & Addington, 2001). Addington & Addington (2001) followed patients in 
their program for one year and found that the specialized substance use treatment 
program within their treatment facility helped to reduce substance use at one year after 
entry into the program. Substance use clearly has serious implications for psychosis and 
must be addressed within treatment programs. 
Sorbara, Liraud, Abalan & V erdoux (2003) studied the impact of substance and 
alcohol misuses on clinical and social outcome over a 2-year follow up after a first 
hospitalization for psychosis. The patients were assessed at six-month intervals. Clinical 
outcomes were explored by assessing re-hospitalization and symptom status. Social 
outcomes were explored by assessing occupational and residential status. They found 
that although there was no association between drug use and social outcomes, but 
persistent drug use increased risk for readmission to hospital and thus, poorer clinical 
outcomes. Their findings suggest therapeutic interventions for substance use (Sorbara et 
al., 2003). 
Pencer & Addington (2003) found no association between substance misuse and 
cognitive functioning among first episode patients. The possible explanation for the 
result was that the level of substance use amongst the sample was not high and/or the 
sample examined was young, and many studies have shown that substance use impairs 
cognitive functioning only after many years of prolonged and excessive use (Pencer & 
Addington, 2003). It is possible that the detrimental effects of substance misuse are not 
yet evident. Thus, they concluded that although there was no association of alcohol 
misuse and cognitive functioning in their young sample, such as long-term use may lead 
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to later problems. Thus, long-term substance use must be stopped~ and intervening early 
at first episodes may help the young people to understand the long-term problems that 
could occurred with continued substance use (Pencer & Addington, 2003 ). 
Suicide & Depression 
It has been estimated that 10% of those suffering from schizophrenia commit 
suicide, and the first year of psychosis has been reported as a particularly high-risk period 
(Addington et al., 2004b). There are several predictors of suicide, such as fewer positive 
and negative symptoms, long DUP, and a history ofparasuicide (i.e. non-fatal deliberate 
physical harm, such as self-injury or overdose) (Addington et al., 2004b). Subjects who 
misused drugs were seven times more likely to engage in suicidal behaviour (V erdoux et 
al., 2001 ). Addington et al. (2004b) conducted a study to determine the prevalence of 
suicidal behaviours prior to and during the first year of treatment in their Calgary early 
psychosis program. Patients were assessed at the entry into the program and one year 
later, using measures such as suicide attempts, depression, positive and negative 
symptoms, social functioning and substance misuse. The program offered treatment in 
depression and suicidal thinking, psychoeducation, individual case management and 
family work. They found that after one year of treatment, the likelihood of attempting to 
commit suicide decreased. They concluded that "specifically designed first episode 
programs can reduce suicidal behaviour in this high-risk population" (Addington et 
al.,2004b). Verdoux et al. (2001) also assessed suicidal behaviour in first admitted 
patients but over a two-year period, and conducted assessments every six months. Their 
study found similar results to Addington, et al. (2004b). Power et al. (2003) also studied 
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suicidal behaviour, but within the EPPIC program in Australia. They developed a 
cognitive therapy called LifeSPAN as a preventive strategy for suicidal patients. In their 
study, they randomly assigned first episode suicidal patients to standard clinical care or 
standard care plus LifeSPAN therapy. They report that the patients offered this 
LifeSPAN therapy showed a reduced risk of suicide as compared to those who were not 
part of this program (Power et al., 2003). 
Depression has been found to play a major part in psychotic illness and a 
precursor to suicide when associated with hopelessness (Jackson & Iqbalt, 2000). It has 
been argued that depression after the onset of psychosis may be a reaction to the changes 
associated with the psychosis itself (Jackson & lqbalt, 2000). Individuals experience a 
major change in their personal lifestyles and commonly express feelings of alienation and 
loss of self-esteem (Jackson & lqbalt, 2000). Chintalapudi, Kulhara & Avasthi (1993) 
found depressed subjects tended to have longer DUP, better premorbid adjustment prior 
to psychosis (i.e. patients psychosocial performance was better prior to the illness) and an 
excess of stressful life events compared to those patients who did not develop depression 
with psychosis. 
Quality of Life/Social Outcome 
Quality of Life is determined by a variety of circumstances such as level of 
social/community functioning, objective life circumstances and, for those with serious 
illness, the symptoms related to health status (Norman et al., 2000). People with mental 
illness are believed to experience lower life satisfaction than the population as whole 
(Blenkiron & Hammill, 2003). Malia, Norman, McLean & Mcintosh (2001b) assessed 
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the impact of community focused treatment programs on different dimensions of self-
reported quality of life of first episode patients. The Wisconsin Quality of Life Scale was 
used to assess subjective aspects of the patients' level of functioning. The nine domains 
included: general satisfaction level (e.g. leisure, housing, sexual activity); activities and 
occupation; psychological well-being (e.g. personal feelings about life); 
symptoms/outlooks; social relations and support; money; and activities of daily living. 
The patients were assessed on these domains for one year following treatment and the 
results showed that the patients had significant improvements in each domain (Malia et 
al., 2001). 
It has been reported that first episode patients have social functioning deficits that 
are equivalent to those seen in more chronic psychotic patients (Addington, Young & 
Addington, 2003). These first episode patients often fail to attain age appropriate social 
and vocational functioning with most remaining unemployed after one and two years of 
treatment (Addington et al., 2003). Addington et al. (2003) study examined social 
functioning of first episode patients in EPP over one year, using the Quality of Life Scale. 
Their study found that after one year there were significant improvements in patient's 
quality of life. McGorry et al. ( 1996) and Malia et al. (200 1) reported similar results. 
These findings are encouraging and supportive of early psychological interventions. 
However, since positive and negative symptoms continue to have an impact on social 
functioning, it is important that treatment programs undertake measures to reduce these 
symptoms, such as supportive employment programs to improve employment outcomes 
(Addington et al., 2003). Addington et al. (2003) also state that since social functioning 
48 
may have been declining for many years, improvement may require more time than just 
one year. 
Family 
Family members do not choose the caregiver role; however they find that they 
become carers of first episode patients. When family members take on the role of 
caregiver, they are likely to suffer increased levels of worry and strain, depression and 
anxiety (Kuipers & Raune, 2000). They are likely to be emotionally upset and have 
anxiety about the future (Kuipers & Raune, 2000). They may also suffer from reduced 
social networks and feel isolated and stigmatized (Kuipers & Raune, 2000). This in tum, 
can be very stressful for the patient. It has been shown that providing early intervention 
programs with family aspects can be beneficial in reducing both the symptoms for the 
patients and the emotional burden of the carers (McGorry et al., 1996; Kuipers & Raune, 
2000). Family interventions can also help prevent relapse amongst patients (McGorry, 
1996; Kuipers & Raune, 2000). Families provide the supportive setting that can help the 
patient overcome the psychotic experience (Kuipers & Raune, 2000). 
Relapse & Recovery 
Prevention of relapse is important for the future well-being of individuals who 
have experienced psychosis (Scott et al., 2004). Every relapse results in an increased 
probability of future relapses, as well as the growth of residual symptoms and 
accompanying social disability (Scott et al., 2004). Studies have shown that relapse is 
usually preceded by subtle changes in behaviour (Scott et al., 2004). Therefore, 
49 
identifying these early warning signs of psychotic relapse can help to reduce the risk of 
relapse (Scott et al., 2004). 
Liberman & Kopelowicz (2005) discuss the importance of setting standard criteria 
to define recovery so that individual patients can be categorized as either achieving 
remission (recovery) or not. In this way, early psychosis programs may be evaluated by 
the number of patients that achieve the criteria for recover at various points in time. For 
example, a definition of recovery would include independent functioning of patients, 
such as being productive in work or school, social relations, family life, and recreational 
activities as well as achieving symptom remission. The individual would be considered 
recovered if one is able to take care of their personal needs without assistance, such as 
managing one's own medication, health and money. An operational definition of 
recovery would help researchers identify the factors that may impede or promote 
recovery and facilitate research on recovery as a therapeutic goal. 
2.13 Propensity Matching Research 
As stated in the above sections, Randomized Controlled Trials (RCTs) have 
ethical challenges when performed on early psychosis patients. However, several studies, 
such as Ascher-Svanum, Zhu, Stensland & Sterling (2003) and Shenyang, Barth and 
Gibbons (2004), who are dealing with vulnerable populations, are now using a new 
evaluation methodology called propensity matching. 
Ascher-Svanum et al. (2003) compared the illness severity of schizophrenia 
patients served at the Veterans Health care Administration with that of Non-Veteran 
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Medicaid patients served at state facilities. The ultimate goal of their study was to 
understand the treatments currently provided to schizophrenia patients and to determine 
which treatment options produced the best outcome of care. Previous studies comparing 
the two groups did not adjust for important patient characteristics, such as age, race and 
age of illness onset. Their study addressed prior methodological issues by comparing the 
two groups while matching on patient's gender, age, race, age at illness onset, and study 
site using propensity score matching. Ascher-Svanum et al. (2003) defined propensity 
score as the conditional probability of being a Veteran patient (Y) given the covariates of 
interest (X) of the individual: gender, age, race, age at illness onset, and study site. 
PS=Pr(Y/X). The Veteran and non-Veteran Medicaid patients were first pooled and the 
logit score for each patient was calculated using the selected covariates. A Veteran 
patient was then selected and matched with a non-Veteran Medicaid patient with the 
closest propensity score. Both patients were then removed from further matching and a 
new Veteran patient was selected, until all Veteran patients were matched with a non-
Veteran Medicaid patients. Once matching was completed, the groups were then 
compared on baseline symptomatology, functional status, quality of life, substance abuse, 
work status, violent behaviour, suicidal tendencies, adherence to medication and prior 
hospitalization using chi-square tests and t-tests. They found that once baseline 
characteristics were adjusted for, their groups could be compared and their results found 
similarities between the two groups on many of the clinical outcomes. 
Shenyang et al. (2004) examined whether substance abuse treatment reduced the 
likelihood of re-reports over an 18 month follow-up period using the Alcohol and Other 
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Drugs (AOD) cases from a treatment program and comparing to cases from the National 
Survey of Child and Adolescent Well-being (NSCA W). The challenge with their study 
was selection bias, i.e. how do they address the concern that cases that did not get 
substance abuse treatment did not need it? To address this problem, they decided to use a 
propensity matching methodology for program evaluation. They identified variables with 
likely linkage to substance abuse treatment, such as marital status, education, poverty, 
employment and age. A propensity score was calculated for each participant, using a 
computational software ST A TA-PSMATCH2, and matched to the non-participants with 
the closest propensity score using the same variables, so that they share almost the same 
characteristics. Therefore, selection bias may be mitigated in the new sample. Once the 
participants and non-participants were matched, Shenyang and co-investigators were 
able to compare the matched cases on what variables predicted the likelihood of the re-
report, such as receipt of welfare, active domestic violence, number of children and 
trouble paying for basic necessities. Their study found once selection bias is controlled 
through matching, substance abuse services are not associated with the likelihood of re-
reports over 18 months. They concluded that when evaluating a program, one can use 
propensity score matching to match the treatment sample to a carefully selected national 
sample to assess the impact of the program. 
Foster (2003) reviewed the propensity matching approach and illustrated its use in 
an analysis of dose response, the relationship between the volume of services received, 
and treatment outcomes. He argues that the benefit of using propensity score matching is 
that one can control or adjust for all known covariates and therefore, can produce more 
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precise estimates of program effects. The data for this study was taken from a well-
known study of children's mental health services, and the analysis estimated the impact 
of outpatient therapy based on comparisons of individuals receiving different treatment 
doses. The comparisons are adjusted for the preexisting observed differences among the 
groups using the propensity score method. They were compared on sex, age, parental 
education and previous services used. Once all baselines differences were accounted for, 
the subjects were compared on dose and outcomes. The analyses of this study using 
propensity score matching suggested that added services improved treatment outcomes, 
especially child functioning. Foster (2003) concludes that "propensity score methods 
represents a promising means for improving comparisons by providing a flexible and 
convenient way to adjust for preexisting between-group differences", and thus, of 
potential value to health services researchers, where randomization is difficult or 
impossible, for them to evaluate treatment programs. 
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CHAPTER3 
METHODOLOGY 
3.1 Early Psychosis Program Setting 
The NL Program was developed in 2001 at the Waterford Hospital, St. John's and 
provides psychiatric treatment services for individuals diagnosed with a first episode of 
psychosis. The NL Program is currently serving a total provincial population of 
approximately 500,000. There are 2 psychiatrists, 1 program coordinator, 3 nurse case 
managers, 1 family worker, 1 pharmacist and a half-time occupational therapist that 
make-up the interdisciplinary team. The main goal of the NL Program is to provide 
optimum, safe and comprehensive assessments, intervention and support for patients with 
a first episode of psychosis and their families for three years. 
3.2 NL Early Psychosis Patient Demographics 
There are currently 150 active patients in the NL Program. New patients are 
continually entered into the NL Program as they become detected and diagnosed with 
first time psychosis. As patients enter the NL Program, they are assigned an identifier 
number. Seven patients discontinued the NL Program due to transferals, relocated or 
were non-compliant to the treatment. For this study, timing for analysis allowed only 
data collected on the first 150 patients to be used. 
Table 1 describes the demographic characteristics of the NL early psychosis patients. 
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AGE SEX MARITAL STATUS LIVING 
DISTRIBUTION ARRANGEMENT 
15-19: 38 (25%) Males: 109 (73%) Single: 130 (87%) Alone: 26 (17%) 
20-24: 60 (40%) Females: 41 (27%) Common-Law: 3 (2%) With Parents: 92 (61%) 
25-29: 26 (17%) Married: 12 {8%) With Spouse: 4 (3%) 
30-34: 7 (5%) Widowed/Divorced: 2 (1 %) Other: 18 (12%) 
35-39: 7 (5%) Not Stated: 3 (2%) Not Stated: 10 (7%) 
40-44: I (1 %) 
45-49: I (1 %) 
50-54: 1 (1%) 
55-59: 2 (1 %) 
3.3 Data Collection of NL Program 
As part of monitoring their treatment in the NL Program, the patients are assessed 
on several scales to measure their clinical and social outcomes. Some scales measure 
patients at entry into the NL Program and every three months thereafter until the three-
year treatment has been completed. Other scales are used only once, every six months or 
every year. The data collected for each patient is entered into the Early Psychosis 
database (here after referred to as the "database"). This database will be used in this 
study's analyses. 
There are fourteen scales used for patient evaluation, all of which will be 
described below. 
a). Diagnosistic Assessment Scale: This scale is used to identify the type of 
disorder from which the patient suffers. The assigned psychiatrist will use this scale to 
assess patients at initiation and then at the end of the first year, second year and third year 
of the program. There are four categories of disorders, psychotic, anxiety, mood and 
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other disorders, with several subtype disorders under each category to clarify the patients' 
specific problem, such as obsessive compulsive disorder under the Anxiety disorder 
category, or major depressive disorder, under the Mood disorder category. 
b). Positive and Negative Syndrome Scale (PANSS): This scale is used to 
measure the presence/absence and severity of the positive and negative symptoms. 
Patients are assessed at initiation and every three months using this scale. The P ANSS is 
a 30-item semi-structured clinical interview that has demonstrated high internal reliability 
and construct validity (Kay et al., 1987). It contains 7 items measuring positive 
symptoms, such as measuring hallucinatory behaviour, 7 items measuring negative 
symptoms, such as measuring emotional withdrawal, and 16 items measuring general 
aspects of psychopathology, such as guilt feelings. The 30 items are rated on a 7-point 
scale from 1 = absent to 7= extreme. 
c). Montgomery-Asberg Depression Rating Scale (MADRS): This scale is used 
to measure the severity of patients' depression symptoms (Montgomery & As berg, 1979). 
Patients are assessed at initiation and every three months using this scale. MADRS is a 
1 0-item scale that rates patients' levels of depression on a scale of 0 to 6, with higher 
scores reflecting greater severity of depression. For example, the apparent sadness item, 
rates the patient from 0= No sadness to 6 =Look miserable all the time. 
d). Calgary Depression Scale for Sczhiophrenia: This scale is also used to 
measure the severity of patients' depression symptoms and suicidal thoughts, since 
research has shown that there is high levels of depression amongst first episode patients. 
Patients are assessed at initiation and every three months using this scale. Addington, 
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Addington & Matricka-Tyndall (1993) developed this scale. It contains 9 items that are 
rated from absent (0) to severe (3). Some items include, depressed mood, hopelessness, 
self-depreciation and suicide. 
e). Premorbid Adjustment Scale: This scale measures current and premorbid 
social functioning. This scale is usually done once by a reliable family member or friend 
who provides the source of information The first twelve items in the scale ask specific 
questions about the history of the patients' childhood to the age they developed 
psychosis, such as normal development, head injuries, health problems and stressors in 
their life that could have contributed to the development of psychosis. The remaining 8 
items rate patients' behaviours at certain ages, such as sociability and withdrawal, peer 
relationships, sexual behaviour and level of occupational and educational activities. The 
scale was developed by Cannon-Spoor, Potkin & Wyatt (1982). 
f). Family History: This scale is done only once, but provides information on the 
history of psychotic disorders in a family. 
g). Quality of Life: This scale assesses the quality of life of patients. They are 
assessed at initiation and every six months. There are 21 items rated on a 7 -point scale, 
with higher ratings indicating better quality of life. Some items include social activity, 
time utilization and activities. Heinrichs, Hanlon & Carpenter (1984) developed this 
scale. 
h). Global Assessment Scale (GAS): This scale is a single-item rating scale for 
evaluation of overall patient functioning during a specified period on a continuum from 
psychiatric illness to health. The scale value ranges from 1 (hypothetically sickest person) 
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to 100 (hypothetically healthiest person), divided into 10 equal intervalsFor example, 31-
40, is a major impairment in several areas, such as work, family relations, judgment, 
thinking or mood OR some impairment in reality testing or communication OR single 
serious suicide attempt. The clinician may feel this range best describes the patient at 
the time of assessment and gives the patient a rating of 34. Luborsky ( 1962) developed 
the GAS. 
i). Clinical Global Impression (CGI): This scale is a three-item scale used to 
assess treatment response in psychiatric patients. The three items are: Severity of Illness; 
Global Improvement and Efficacy Index. The Severity of Illness item is rated on a seven 
point scale ( 1 =normal to ?=extremely ill) and requires the clinician to rate the severity of 
the patient's illness at the time of assessment, relative to the clinician's past experience 
with patients who have the same diagnosis. Considering total clinical experience, a 
patient is assessed on severity of mental illness at the time of rating according to: normal 
(not at all ill); borderline mentally ill; mildly ill; moderately ill; markedly ill; severely ill; 
or extremely ill. The Global Improvement item is rated on a seven-point scale (1 =very 
much improved to 7=very much worse) and requires the clinician to rate how much the 
patient's illness has improved or worsened relative to a baseline state. The Efficacy 
Index is rated on a four-point scale (from 'none' to 'outweighs therapeutic effect'). 
Patients are assessed at initiation and every three months thereafter. 
j). Barnes Akathisia Rating Scale (BAS): This scale measures akathisia, which is 
a frequent and common adverse effect that can occur as a result of treatment with 
antipsychotic drugs. Reported prevalence rates vary between 5 and 36.8% (See Miller & 
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Fleischhacker, 2000). The Barnes Akathisia Rating Scale is a four-item scale used to 
assess the presence and severity of drug-induced akathisia. It is the most widely used 
comprehensive rating scale for akathisia, including both objective items (eg observed 
restlessness) and subjective items ( eg patient's awareness of restlessness and related 
distress), together with a global clinical assessment of akathisia. Global assessment is 
made on a scale of 0 to 5 with comprehensive definitions of akathisia provided to scale 
patients of having akathisia: O=absent; 1 =questionable; 2=mild akathisia; 3=moderate 
akathisia; 4=marked akathisia; 5=severe akathisia. The patients are assessed at entry into 
the program and every three months using this scale. 
k). Young Mania Rating Scale (YMRS): This scale is an 11-item instrument used 
to assess the severity of mania in patients. The 11 items are: Elevated Mood, Increased 
Motor Activity Energy, Sexual Interest, Sleep, Irritability, Speech (Rate and Amount), 
Language- Thought Disorder, Content, Disruptive- Aggressive Behaviour, Appearance 
and Insight. The patients are rated in each item by a 4-point range, 0= absent to 4= 
severe. Patients are assessed at entry and every three months. Ratings are based on 
patient self-reporting, combined with clinician observation. Young, Biggs, Ziegler & 
Meyer (1978) developed YMRS. YMRS is a reliable and commonly used assessment 
tool of proven validity, which has been used in clinical practice since 1978. 
I). Extrapyramidal Side Effect Rating Scale (ESRS): The scale assesses the extent 
of damage to the extrapyramidal system and the motor functions that it controls. This 
scale consists of 12 multipart items, four of which are general neurological assessments 
and eight of which are specific to the symptoms of Parkinson's disease. The items are 
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rated on a scale of 0 to 6 of severity of the person. The higher the score, the greater the 
effect symptoms have on function. Patients are assessed at entry and every three months 
using this scale. Chouinard et al., (1980) developed the ESRS. 
m). UKU Side Effect Rating Scale: This scale was developed to provide a 
comprehensive side effect rating scale with well-defined items to assess the side effects 
of psychopharmacological medications. The rating is formed on the basis of an interview 
with the patient and other relevant information from all available sources. The clinician's 
observations are given more weight than patient reports. This scale contains 48 items. 
Rating is independent of whether the symptom is regarded as being drug-induced. The 
rating is either not assessed, present or not present. If there is a probability of the causal 
relationship (or lack of it) of each item to the medication in question is indicated in a 
separate column, which makes it useful for determining subsequent course of action. 
Lingjaerde et al., (1987) developed this scale. The scale assesses patients at entry and 
three months thereafter. 
n). Case Manager Rating Scale for Substance Use Disorder: This scale rates 
patient's use of alcohol and other drugs over six month intervals. The rating is based on 
evidence from self-report, interviews, behavioral observations and/or family reports. The 
scale used ranges from 0 (no substance use) to 4 (extremely severe substance use). This 
scale is based on the Drake (1990) scale of diagnosis of Alcohol Use Disorders in 
Schizophrenia. 
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3.4 The Study Design 
To evaluate the impact of the NL Program, it was decided to compare the NL 
Program's patients to a national population to determine if the NL Program helps 
improve patients on several clinical and social outcomes from initiation to the end of the 
three-year program. Two national population databases were considered as a control 
group: the National Population Health Survey and the Canadian Community Health 
Survey. Information about both databases can be found at www.statcan.ca. Each survey 
was carefully reviewed to determine if they could have similar characteristics to 
potentially match the NL Program. 
The National Population Health Survey (NPHS) collected information related to 
the health of the Canadian population and related socio-demographic information. There 
are three cycles of data collection. The first cycle of data collection began in 1994. The 
data will then be continued to be collected every second year thereafter, for 
approximately 20 years in total. Three cycles of collection are now completed: NPHS 
Cycle 1 ( 1994-1995), NPHS Cycle 2 ( 1996-1997) and NPHS Cycle 3( 1998-1999). NPHS 
Cycle 3 is a longitudinal study, which consists of all respondents chosen in Cycle 1 who 
had completed at least the general component of the questionnaire in 1994-1995. The 
questionnaire includes questions related to health status, use ofhealth services, 
determinants ofhealth. chronic conditions and activity restrictions. This questionnaire 
did have a mental health section, but it was very limited. Thus, although it was a 
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longitudinal study, NPHS was not considered a good candidate population to match with 
the early psychosis patients. 
The Canadian Community Health Survey (CCHS) Cycle 1.2, Mental Health and 
Well-being was designed to address priority mental health determinants, mental health 
status and mental health system. The topic selection for the content of CCHS was 
conducted through a process of extensive consultation with regional, provincial and 
federal representatives and the research community. The selection of mental disorders as 
well as mental well-being areas were a result of discussions with the Mental Health 
Expert Group assembled for the survey, as well as the Population Health Advisory 
Committee. These topic areas matched topic areas addressed at the NL Program, such as 
Alcohol Dependence and Use, Illicit Drug Use and Dependence, Medication Use, Mental 
Health Services, Psychological Well-being, Stress, Spiritual Values, Social Phobia and 
Social Support. Therefore, CCHS provided good data to potentially match the NL 
Program. However, CCHS is a cross-sectional study, meaning that the study only 
questioned individuals at one point in time. Therefore, in order to compare the early 
psychosis patients at initiation and three-years later, two different points in time, two 
cohorts from the CCHS population would have to be used. 
Thus, after carefully reviewing both surveys, it was decided that the CCHS would 
supply the best population to use as a control group, since there is substantial overlap of 
characteristics to match with the NL early psychosis patients. 
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3.5 Benchmarking to an Age-Representative Population 
The main purpose of benchmarking is to compare the NL early psychosis patients 
with the rest of the national population, to identify how different these patients are at the 
beginning of treatment and then how comparable they are to the population average at the 
end of the program. Several variables, such as education, employment, substance use, 
quality of life, depression and functional status will be examined. To compare to a 
national population average, the CCHS is the best choice since it was completed by a 
variety of people (36, 984). Therefore, this is a large sample to use for an age-specific 
and region-specific group. 
This study's first aim in using the CCHS is to benchmark the NL patients with the 
CCHS population of the same age group and from a specific region to compare the 
groups when the patients entered and then completed the program. This study will use 
the CCHS population from Atlantic Canada. Since the majority of those who develop 
early psychosis are between the ages of 15-29, the CCHS population will also be taken 
from that age range. There are 1461 people surveyed in Atlantic Canada that are between 
the ages of 15-29. 
Since the CCHS was done at only one point in time, a cross-sectional study, it 
was decided to increase the age range to 15-34 years, the next interval in the age category 
of the CCHS to assess the population after 2 years. This is considered the best way to 
measure the CCHS at the second point in time since the NL patients would have 
increased in age by two years. There are 2073 patients between the ages of 15-34. 
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Table 2 describes the demographic characteristics of the Atlantic Canada Population. 
11 bl 2 D a e . emogra h. Ch pi lC ifCCHSAtl t" C d P I . aracterzstzcs o an zc ana a opu atzon 
AGE SEX MARITAL STATUS LIVING 
DISTRIBUTION ARRANGEMENT 
15-19: 552 (27%) Males: 879 (42%) Single: 1169 (56%) Alone: 322 (15%) 
20-24: 466 (22%) Females: 1194 (58%) Common-Law: 252 (12%) With Parents: 833 (40%) 
25-29: 443 (21%) Married: 569 (27%) With Spouse: 757 (37%) 
30-34: 612 (30%) Widowed/Divorced: 78 (4%) Other: 146 (7%) 
Not Stated: 5 (0.2%) Not Stated: 15 (l%) 
The second part of this study will use the CCHS population to propensity match 
the early psychosis patients with the CCHS population who has displayed symptoms of 
psychosis. From the survey data file, 411 people stated they have psychosis, taken from 
question 281: Do you have any psychosis? Within the 411 people, 360 people ranged 
between the ages of 15-59 years. Therefore, these 360 people will serve as the psychotic 
population. Table 3 describes the demographic characteristics ofthese 360 people. 
Table 3. Demographic Characteristics ofCCHS With Psychosis 
AGE SEX MARITAL STATUS LIVING 
DISTRIBUTION ARRANGEMENT 
15-19: 21 (6%) Males: 166(46%) Single: 171 (48%) Alone: 187 (52%) 
20-24: 35 (10%) Females: 194 (54%) Common-Law: 22 (6%) With Parents: 38 (1 0%) 
25-29: 28 (8%) Married: 80 (22%) With Spouse: 93 (26%) 
30-34: 48 (13%) Widowed/Divorced: 87(24%) Other: 42 (12%) 
35-39: 51 (14%) 
40-44: 48 (13%) 
45-49: 54 (15%) 
50-54: 38 (ll%) 
54-59: 37 (10%) 
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3.6 The Study Procedure 
Part One 
The first analysis is a pre-post examination of the NL Program. This is done to 
compare traditional methodology with the later analyses of propensity matching to see 
which method shows a greater treatment effect. To perform the pre-post, only the early 
psychosis database will be used. 120 patients were used to perform the pre-post 
methodology. The results are derived from 120 patients who have been in the program 
for a period of at least two years. The 120 patients are evaluated at entry into the 
program, first year, second year and then three years later, to determine a treatment effect 
on the social and clinical outcomes. However, often there were patients that were not 
assessed at all three-month intervals. Therefore, if there is no patient assessment data at 
12, 24 and 36 months, the mean of the assessment data for months before and after the 
entry points is used. For example, ifthere is no entry for the 12-month interval, then the 
mean of 9 and 15-month entries are used. This increases the number of patients to be 
assessed. The patients are first assessed on eight scales to see if there are any treatment 
effects. The scales used in this pre-post approach are Quality of Life, The Case 
Managers Rating Scale for Substance Use Disorder, The Calgary Depression Scale, 
YMRS, MADRS, P ANSS, BAS, and GAS. Then to further examine program treatment 
effects, several variables on each of the clinical scales will be assessed such as quality of 
life, substance use, suicidal tendencies, sleep habits, aggressive behaviour, insight, 
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hospitalization, education, employment, depression and functional status. All 
computations will be performed using SPSS-one sample t-tests. 
Part Two 
In the second part of the analysis, comparisons are made with the CCHS Atlantic 
population by benchmarking to the same age. The matched individuals are then 
compared twice, once for the initiation of early psychosis patients into the NL Program to 
see if they differ from the population at entry, and secondly, at the end of two years into 
the NL Program for the early psychosis patients to see if they converge back to the 
population. The end of two years was chosen since most patients have not yet reached 
program completion (three years). The clinical and social outcomes that is used to 
compare the individuals are: quality of life, substance use, suicidal tendencies, 
hospitalization, education, employment, depression and functional status. Some of the 
variables are similar to those matched in the pre-post. The variables are matched by 
comparing items on the early psychosis scales with items answered in CCHS. Therefore, 
only certain variables that are used in the pre-post can be used here since the questions 
from both databases had to be matched as closely as possible. Data analyses for the 
comparisons will be performed using SPSS-independent sample t-tests. Convergence at 
two years is indicated when the t-value is non-significant, i.e. suggesting the patients did 
not differ from the population after two years of treatment. In some cases, the t-value 
may be significant at two years, but the t-value at two years may be smaller than at 
initiation. This suggests that although the treatment effects tend to be small, there is a 
trend towards convergence. 
66 
Below are examples of matched question variables from the early psychosis 
scales and the CCHS questions. The remaining matched variables can be found in 
Appendix G. EPP is abbreviation for Early Psychosis Program. 
Question 2: Distress related to restlessness: Each scale rated this question as: 
EPP (From BAS scale): No distress (0), Mild (1), Moderate (2), Severe (3) 
CCHS: All of the time (1), most of the time (2), some of the time(3), little of the time(4), 
none of the time( 5) ( disb _1 Oe) 
Therefore, the MATCHED QUESTION FOR EPP-CCHS: Distress related to 
restlessness: 
O=No distress (CCHS none of the time 5) 
1= Mild (CCHS little ofthe time (4)) 
2= Moderate (CCHS some of the time (3)) 
3= Severe (CCHS all ofthe time (1) and most ofthe time (2)) 
Q14. Drank Alcohol in the last 12 months: 
CCHS: Yes (1), No (1), not applicable (6), not stated (9) (alcb_1) 
EPP (Case Manager Rating Scale for Substance Use Disorder) Alcohol: None (0), Mild 
(1), Moderate (2), Severe (3), Extremely Severe (4) 
MATCHED QUESTION FOR EPP-CCHS: Alcohol: 
1. Yes (EPP 1, 2, 3 and 4) 
2. No (EPP 0) 
Part Three 
The third analysis is propensity matching the NL early psychosis patients with 
those members of the CCHS population who have psychosis as an alternative method to 
the pre-post comparison. This study originally envisioned performing propensity 
matching similar to that described by Ascher-Svanum et al. (2003). For example, the 
matching would be performed on four variables: age, gender, marital status, and living 
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circumstance. The propensity score would be defined as the conditional probability of 
being an early psychosis patient (Y) given the covariates of interest (X) ofthe individual: 
age, gender, marital status and living circumstance: PS=Pr(Y/X). Using these selected 
characteristics, a propensity score would be calculated for each individual in both groups 
using SPSS. An NL early psychosis patient would then be randomly selected and 
matched with a CCHS individual with the closest propensity score. Both individuals 
would then be removed from further matching, and a new patient would be selected until 
they are all matched. However, the CCHS sample size of 132 people was too small to 
calculate a propensity score to individually match the CCHS group with the NL early 
psychosis patients. Propensity matching, as described above, can only be used with a 
large population. Therefore, this study will perform a difference of differences approach 
as a propensity matching method. 
Difference of differences approach is used to model the treatment effect by 
estimating the difference between outcome measures at two points in time for both those 
receiving the treatment and the controls (those not participating in the program) and then 
comparing the difference between the two groups (Buckley & Shang, 2003). For 
example, on the outcome variable sleep, if the NL patient was 60% at entry and then 52% 
at two years and the CCHS was 40% at entry and 37% in two years, it shows that 
although there is a difference between the groups, the NL patient group is narrowing the 
gap and converging towards the population. However, this is not showing a program 
effect. Any differences found here of narrowing the gap may only suggest the NL 
patients are getting older and therefore, any changes maybe a result of maturation or 
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hormones. However, going a step further by differencing the differences, that is, 
differencing the trajectory of the NL patients on these variables, such as taking the 
difference ofthe NL patients' trajectory of sleep towards the CCHS population, would 
identify any NL Program effects. This technique ensures that any variables (i.e. 
maturation or hormonal effects) not observed, but are correlated with the individuals and 
the outcome variables, will not bias the treatment effect (Buckley & Shang, 2003). The 
key assumption of the difference of differences approach is that the analyst assumes that 
unmeasured factors or changes affect both the participants and the non-participants in 
similar ways (Buckley & Shang, 2003). This methodology employs the propensity 
matching technique, whereby there is a small control sample to match. 
Therefore, this study will use the difference of differences approach (inference 
about the difference between two means when there are independent samples). The 
criteria necessary to perform this type of propensity matching are that ( 1) the CCHS 
group had psychosis (answered yes to question 281) and that (2) they were of age-
specific relevance (15-29 age range to match at initiation of the program and 15-34 age 
range to match two years later). The groups will first be compared on how different the 
NL group is from the CCHS group upon entry into the program and then at two years 
later. The groups are compared on the same social and clinical variables that are used in 
Part Two, which included quality of life, substance use, suicidal tendencies, 
hospitalization, education, employment, depression and functional status. The data will 
be analyzed using the difference of differences t-tests. 
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3. 7 Ethical Considerations 
The rights of the patients participating in this evaluation study are protected to the 
fullest extent possible. This was accomplished by getting approval on every aspect of 
this study. 
First, a letter was written in January 2005 requesting the Coordinators of the NL 
Program to give permission to conduct research on the program and to use their database 
(See Appendix A). Permission was obtained from the Coordinators in January 2005 (See 
Appendix B). 
Second, in January 2005, an ethics application was filled out describing in detail 
the Study's objectives and the use of a hospital database. This application was forwarded 
to the Memorial University Faculty of Medicine Human Investigation Committee (HIC) 
(See Appendix C). In February 2005 ethics approval was granted by HIC to pursue this 
Study (See Appendix D). 
Third, in February 2005, another ethics application describing the Study was sent 
to Resource Proposal Approval Committee (RP AC) for using the Health Care 
Corporation of St. John's database (See Appendix E). Permission was granted in March 
2005 (See Appendix F). Therefore, full approval was granted to perform this study. 
The NL Program database was stored on computer files that were password-
protected and accessible only by the principal investigator, the Studies Supervisor and the 
NL early psychosis program Coordinators. To protect privacy and confidentiality, 
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numerical identifiers that are associated with individual information were used during 
analysis. All information is untraceable to any study participant. 
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CHAPTER4 
RESULTS 
4.1 Pre-Post Results on Patient Assessment Scales 
120 patients are assessed on multiple clinical scales at entry, first, second and 
third year into the NL Program using one-sample t-tests. The results for the treatment 
effects from entry to first year are presented in Table 4. This study found significant 
improvements in the patients on all the scales (p~ 0.01), except for the BAS scale. 
The results for the treatment effects from the first to second year are presented in 
Table 5. During this time interval, only two scales show significant patient 
improvements. YMRS scale shows significant treatment improvement for patients at 
p~ 0.01 and MADRS shows significant treatment improvement for patients at p~ 0.05. 
The results for the treatment effects from the second to third year of the NL 
Program are presented in Table 6. During this time interval, patients show no statistically 
significant improvements on any ofthe 8 scales assessed (p:2: 0.10). 
Table 4. Pre-Post treatment results for the first year on the patient 
assessment scales 
SCALE MEAN MEAN MEAN t-value 
(INITIAL) (12 DIFFERENCE 
MONTHS) 
PANSS 75.86 47.78 28.1127 11.713 
p=O.OOO*** 
GAS score 42.18 64.97 23.0278 10.933 
(n=90) p=O.OOO*** 
Calgary 2.54 0.7324 1.8182 4.227 
Depression p=O.OOO*** 
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MADRS 13.90 5.10 8.9375 5.388 
p=O.OOO*** 
YMRS 9.12 3.04 5.8000 5.913 
p=O.OOO*** 
Substance Use 3.67 1.80 1.7600 6.063 
p=O.OOO*** 
Quality of Life 65.29 79.44 13.7792 3.772 
p=O.OOO*** 
BAS 0.76 0.47 0.2639 1.368 
p=0.175 
p:::;-0.01*** p:::;-0.05** p:::;-0.10* 
Table 5. Pre-Post treatment results between 12-24 months on the patient 
assessment scales 
SCALE MEAN MEAN MEAN t-value 
(INITIAL) (12 DIFFERENCE 
MONTHS) 
PANSS 47.78 46.18 -0.6053 -0.289 
p=0.774 
GAS score 64.97 67.32 2.3429 1.448 
(n=70) p=0.152 
Calgary 0.7324 0.800 -0.1316 -0.419 
Depression p=0.677 
MADRS 5.10 4.05 -1.8636 -2.217 
p=0.038** 
YMRS 3.04 1.80 2.0556 3.403 
p=0.01 *** 
Substance Use 1.80 1.80 0.2444 1.132 
p=0.264 
Quality of 79.44 81.40 2.1000 1.120 
Life _1)_=0.268 
BAS 0.47 0.49 -0.1500 -1.062 
p_=0.295 
p:::;O. OJ*** p:::;-0. 05** p:::;-0.10* 
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Table 6. Pre-Post treatment results between 24-36 months on the patient 
assessment scales 
SCALE MEAN MEAN MEAN t-value 
(INITIAL) (12 DIFFERENCE 
MONTHS) 
PANSS 46.18 47.80 -1.6087 -0.670 
p=0.510 
GAS score (n=34) 67.32 67.65 1.0147 0.317 
p=0.753 
Calgary 0.800 0.5667 -0.0833 -0.303 
Depression p=0.765 
MADRS 4.05 4.93 -0.6250 -1.321 
p=0.200 
YMRS 1.80 2.63 -0.5000 -0.796 
p=0.434 
Substance Use 1.80 1.79 -0.3846 -1.631 
p=0.115 
Quality of Life 81.40 87.83 2.3571 0.858 
p=0.399 
BAS 0.49 0.53 -0.1739 -0.723 
p=0.477 
p~O.OJ*** p~0.05** p~O.JO* 
4.2 Pre-Post Results on Variables Within The Scales 
120 patients are assessed on several scale variables at entry, first, second and third 
years into the NL Program using one-sample t-tests. Patient data on school and 
employment rates were only available at entry and at two years. Therefore, these 
variables are assessed for a two-year range using one-sample t-tests. 
The results for the treatment effects on the variables from entry to the first year 
arc presented in Table 7. Over the first year, patients are showing statistical significant 
improvements at p::; 0.01 on PANSS delusions, conceptual organizations, hallucinatory 
behaviour, suspiciousness, emotional withdrawal, difficulty in abstract thinking, 
74 
stereotyped thinking, anxiety, guilty feelings, depression, unusual thought content, 
disorientation, poor attention, lack of judgment and insight, disturbance of volition and 
active social avoidance; CGI scale severity of the illness; The Calgary Depression scale 
depressed mood; MADRS apparent sadness, reduced sleep, concentration difficulties, 
pessimistic thoughts and suicidal thoughts; YMRS sleep, irritability, content, disruptive 
behaviour and insight into the illness; The Case Managers Rating Scale for Substance 
Use Disorder alcohol, cannibinoids, and hallucinogens use; and Quality of Life Scale on 
social activity, social withdrawal, sociosexual relations, extent of quality of life, 
adequacy of quality of life, underemployment, sense of purpose, motivation, time 
utilization and activities. 
Patients are showing significant treatment improvements at p:::; 0.05 for P ANSS 
passive/social apathetic withdrawal variable, and The Calgary Depression scale 
hopelessness and suicide. 
There are no significant differences (p~ 0.1 0) for the following variables: CGI 
global improvement; The Calgary Depression Scales self-depreciation; MADRS lassitude 
and inability to feel; YMRS speech; The Case Manager's Rating Scale for Substance Use 
Disorder cocaine use; ESRS restlessness; and BAS objective, subjective and distress 
related to restlessness. 
Table 7. Pre-Post treatment results for the first 12 months on several variables 
within the scales 
VARIABLE MEAN MEAN MEAN t-value 
(INITIAL) (12 DIFFERENCE 
MONTHS) 
Delusions (n=88) 4.26 2.00 2.1932 10.225 
p=O.OOO*** 
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Conceptual 2.72 1.55 1.0966 8.012 
Disorganization p=O.OOO*** 
(n=88) 
Hallucinatory 3.11 1.50 1.4648 7.345 
Behaviour (n=71) p=O.OOO*** 
Suspiciousness 3.77 1.87 1.8125 10.170 
(n=88) p=O.OOO*** 
Emotional 2.46 1.94 0.5625 3.911 
withdrawal (n=88) p=O.OOO*** 
Passive/ Apathetic 2.27 1.95 0.2784 1.993 
Social withdrawal p=0.049** : 
(n=88) 
Difficulty in 3.00 2.56 0.4148 3.077 
abstract thinking p=0.003*** 
(n=88) 
Stereotyped 2.25 1.66 0.5114 4.010 
Thinking (n=88) p=O.OOO*** 
Anxiety (n=88) 2.95 1.79 0.9830 7.595 
p=O.OOO*** 
Guilt Feelings 2.15 1.40 0.6932 4.669 
(n=88) p=O.OOO*** 
Depression (n=88) 2.47 1.69 0.6989 4.632 
p=O.OOO*** 
Unusual Thought 2.91 1.78 1.0852 6.755 
Content (n=88) p=O.OOO*** 
Disorientation 1.27 1.13 0.4830 4.865 
(n=88) p=O.OOO*** 
Poor attention 2.44 1.46 0.9148 6.750 
(n=88) p=O.OOO*** 
Lack of judgment 3.59 2.04 1.4602 7.753 
and insight (n=88) p=O.OOO*** 
Disturbance of 2.18 1.58 0.4830 4.342 
Volition (n=88) p=O.OOO*** 
Active social 2.59 1.43 1.0284 6.178 
avoidance (n=88) p=O.OOO*** 
Severity of the 4.46 2.42 1.8889 10.348 
Illness (n=90) p=O.OOO*** 
Global 1.28 1.73 -0.500 -1.232 
Improvement p=0.237 
(n=l6) 
Depressed Mood 0.63 0.32 0.3095 3.732 
(n=84) p=O.OOO*** 
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Hopelessness 0.31 0.11 0.2083 3.253 
(n=84) p=0.02** 
Self-Depreciation 0.37 0.32 0.0833 1.075 
(n=84) p=0.286 
Suicide (n=84) 0.23 0.08 0.1726 2.378 
p=0.02** 
Apparent Sadness 1.41 0.36 0.9070 4.554 
(n=43) p=O.OOO*** 
Reduced Sleep 1.56 0.35 1.1754 4.538 
(n=43) p=O.OOO*** 
Concentration 2.07 1.03 0.6744 2.691 
Difficulties p=0.010*** 
(n=43) 
Lassitude (n=43) 1.20 0.79 0.2209 1.055 
p=0.297 
Inability to feel 1.28 0.63 1.0000 1.000 
(n=2) p=0.500 
Pessimistic 1.48 0.59 0.8605 3.998 
Thoughts (n=43) p=O.OOO*** 
Suicidal Thoughts 0.85 0.25 0.6512 2.770 
(n=43) p=0.008*** 
Sleep (n=73) .81 .24 0.6111 6.278 
p=O.OOO*** 
Irritability (n=73) 1.00 0.50 0.5449 4.667 
p=O.OOO*** 
Speech (n=73) 0.91 0.29 -0.0548 -0.754 
p=0.453 
Language (n=73) 0.90 0.25 -0.059 -2.217 
p=O.OOO*** 
Content (n=73) 1.70 0.48 1.0500 5.278 
p=O.OOO*** 
Disruptive 0.67 0.24 0.4278 3.001 
Behaviour (n=73) JJ=0.003 * * * 
Insight (n=73) 1.35 0.57 0.7667 4.959 
p=O.OOO*** 
Alcohol Use 1.41 1.01 0.3525 3.485 
(n=94) p=O.OOl *** 
Cannibinoids Usc 1.55 0.68 0.7632 5.970 
(n=94) p=O.OOO*** 
Cocaine Use 0.17 0.04 0.0947 1.630 
(n=94) p=0.106 
Hallucinogens 0.28 0.05 0.2421 3.394 
Use (n=64) p=0.001 *** 
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Social Activity 2.95 3.82 0.8416 5.271 
(n=1 01) p=O.OOO*** 
Social Network 3.14 3.77 0.5545 3.666 
(n=101) p=O.OOO*** 
Social withdrawal 3.28 3.97 0.6634 3.842 
(n=1 01) p=O.OOO*** 
Sociosexual 2.05 2.84 0.6931 3.885 
relations (n= 1 01) p=O.OOO*** 
Extent ofQOL 2.70 3.49 0.7100 2.994 
(n=101) p=0.003*** 
Adequacy of QOL 2.26 3.40 1.1287 5.824 
(n=101) p=O.OOO*** 
Underemployment 2.56 3.52 0.9455 4.140 
(n=101) _p=O.OOO*** 
Sense of purpose 3.08 3.76 0.6950 4.570 
(n=101) p=O.OOO*** 
Motivation 3.24 4.06 0.9257 6.035 
(n=101) p=O.OOO*** 
Time Utilization 3.27 4.18 0.8663 4.246 
(n=101) p=O.OOO*** 
Activities (n=lOl) 3.83 4.59 0.8267 4.877 
p=O.OOO*** 
ESRS 1.32 1.22 0.0705 0.913 
Restlessness p=0.364 
(n=78) 
BAS objective 0.16 0.06 0.0659 1.618 
(n=91) p=0.109 
BAS subjective 0.34 0.22 0.1099 1.637 
(awareness of p=0.105 
restlessness) 
(n=91) 
Distress related to 0.07 0.04 0.0110 0.332 
restlessness n=91) p=0.741 
p:::;O. OJ*** p:::;O. 05** p:::;O.l 0* 
The results for the treatment effects on the variables from first to second year are 
presented in Table 8. Over the second year in the NL Program, this study found 
significant improvements (p~ 0.01) on YMRS speech variable. There are significant 
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results at p:s;; 0.05 for patients on PANSS difficulty in abstract thinking variables and BAS 
objective. The variables that show statistically significant improvements for patients at 
p:s;; 0.10 are P ANSS poor attention; and MADRS concentration difficulties and 
pessimistic thoughts. The rest of the variables are not statistically significant (p~ 0.1 0). · 
Table 8. Pre-Post treatment results between 12-24 months on several variables 
within the scales 
VARIABLE MEAN MEAN MEAN t-value 
(INITIAL) (12 DIFFERENCE 
MONTHS) 
Delusions (n=62) 2.00 1.99 -0.2339 -1.290 
p=0.202 
Conceptual 1.55 1.54 -0.1250 -0.828 
Disorganization p=0.413 
(n=62) 
Hallucinatory 1.50 1.61 0.0648 0.548 
Behaviour (n=54) p=0.586 
Suspiciousness 1.87 1.86 -0.2016 -1.653 
(n=62) p=0.103 
Emotional 1.94 2.06 -0.1774 -1.591 
withdrawal (n=62) p=0.117 
Passive/ Apathetic 1.95 2.06 -0.1048 -0.812 
Social withdrawal p=0.420 
(n=62) 
Difficulty in 2.56 3.15 -0.6855 -4.754 
abstract thinking p=O.OOO** 
(n=62) 
Stereotyped 1.66 1.69 -0.1855 -1.588 
Thinking ( n=62) p=0.118 
Anxiety (n=62) 1.79 1.71 0.0242 0.157 
p=0.876 
Guilt Feelings 1.40 1.38 -0.0645 -0.629 
(n=62) p=0.531 
Depression (n=62) 1.69 1.50 0.1774 1.281 
p=0.205 
Unusual Thought 1.78 1.68 0.0242 0.158 
Content (n=62) p=0.875 
Disorientation 1.13 1.10 0.0161 0.306 
(n=62) p=0.760 
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Poor attention 1.46 1.53 -0.1774 -1.943 
(n=62) p=0.057* 
Lack of judgment 2.04 1.99 -0.1290 -0.662 
andinsight(n=62) p=0.510 
Disturbance of 1.58 1.56 -0.1290 -1.604 
Volition (n=62) p=O.ll4 
Active social 1.43 1.43 -0.0565 -0.399 
avoidance (n=62) p=0.691 
Severity of the 2.42 2.16 0.1571 1.008 
Illness (n=70) p=0.317 
Global 1.73 1.45 0.0857 0.602 
Improvement p=0.542 
(n=70) 
Depressed Mood 0.32 0.29 0.0403 0.546 
(n=62) p=0.587 
Hopelessness 0.11 0.10 0.0323 0.646 
(n=62) p=0.521 
Self-Depreciation 0.32 0.27 0.0429 0.725 
(n=70) p=0.471 
Suicide (n=62) 0.08 0.06 0.0242 0.554 
p=0.582 
Apparent Sadness 0.36 0.33 0.0556 0.479 
(n=45) p=0.634 
Reduced Sleep 0.35 0.16 0.0778 0.463 
(n=45) p=0.646 
Concentration 1.03 0.94 -2.111 -1.908 
Difficulties p=0.063* 
(n=45) 
Lassitude (n=45) 0.79 0.70 -0.0778 -0.627 
p=0.534 
Inability to feel 0.63 0.53 0.1087 0.489 
(n=23) p=0.630 
Pessimistic 0.59 0.69 -0.2222 -1.727 
Thoughts (n=45) p=0.091 * 
Suicidal Thoughts 0.25 0.21 -0.0667 -0.596 
(n=45) p=0.554 
Sleep (n=60) 0.24 0.15 -0.0167 -.219 
p=0.827 
Irritability (n=60) 0.50 0.49 -.0750 -0.689 
p=0.493 
Speech (n=91) 0.29 0.13 0.0333 0.389 
p=0.698 
80 
Language (n=60) 0.25 0.20 0.0333 0.505 
p=0.616 
Content (n=91) 0.48 0.32 5.0495 9.520 
p=O.OOO*** 
Disruptive 0.24 0.20 -0.0250 -0.258 
Behaviour (n=60) p=0.797 
Insight (n=60) 0.57 0.31 0.0500 0.497 
p=0.621 
Alcohol Use 1.01 1.02 0.0391 0.431 
(n=64) p=0.668 
Cannibinoids Use 0.68 0.67 -0.0703 -0.716 
(n=64) p=0.477 
Cocaine Use 0.04 0.03 0.0313 1.000 
(n=64) p=0.321 
Hallucinogens 0.05 0.03 0.0469 1.350 
Use (n=64) p=0.182 
Social Activity 3.82 3.91 0.1094 0.748 
(n=64) p=0.457 
Social Network 3.77 3.82 0.1563 1.010 
(n=64) p=0.316 
Social withdrawal 3.97 4.09 0.1094 0.754 
(n=64) p=0.453 
Sociosexual 2.84 2.79 0.0625 0.429 
relations (n=64) p=0.670 
Extent ofQOL 3.49 3.79 0.3438 1.322 
(n=64) p=0.191 
Adequacy of 3.40 3.59 0.1719 0.794 
QOL(n=64) p=0.430 
Underemployment 3.52 3.83 0.3203 1.477 
(n=64) p=0.145 
Sense of purpose 3.76 3.95 0.1797 1.215 
(n=64) p=0.229 
Motivation (n=64) 4.06 4.12 0.0391 0.250 
p=0.803 
Time Utilization 4.18 4.44 0.2296 1.238 
(n=64) p=0.220 
Activities (n=64) 4.59 4.71 0.2266 1.570 
p=O.l21 
ESRS 1.22 1.20 0.000 0.000 
Restlessness p=l.OOO 
(n=58) 
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BAS objective 0.06 0.11 -0.1000 -2.187 
(n=60) p=0.033** 
BAS subjective 0.22 0.16 0.0167 0.299 
(awareness of p=0.766 
restlessness) 
(n=60) 
Distress related to 0.04 0.05 -0.0167 -0.574 
restlessness p=0.568 
(n=60) 
p~O.OJ *** p~0.05** p~O.JO* 
The results for the treatment effects on the variables from second to third year are 
presented in Table 9. This study found significant improvements (p~ 0.01) during the 
third year in the NL Program on P ANSS difficulty in abstract thinking and YMRS 
content. 
There are significant patient improvements at p~ 0.05 for The Calgary Depression 
Scale self-depreciation; MADRS lassitude and inability to feel; and YMRS insight. 
Patients also show statistical significance on the following variables at 
p~ 0.10: PANSS emotional withdrawal, stereotyped thinking and unusual thought 
content; The Calgary Depression scale depressed mood; MADRS apparent sadness; and 
Quality of Life Scale social activity. 
Patients did not show statistically significant improvements on the remaining 
variables during this time interval (p~O.l 0). 
Table 9. Pre-Post treatment results between 24-36 months on several variables 
within the scales 
VARIABLE MEAN MEAN MEAN t-value 
(INITIAL) (12 DIFFERENCE 
MONTHS) 
Delusions (n=36) 1.99 2.03 -0.0972 -0.584 
p=0.563 
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Conceptual 1.54 1.47 0.1389 0.896 
Disorganization p=0.377 
(n=36) 
Hallucinatory 1.61 1.60 -0.1250 -0.801 
Behaviour (n=36) p=0.429 
Suspiciousness 1.86 1.71 0.0833 0.505 
(n=36) p=0.616 
Emotional 2.06 2.24 -0.2917 -1.950 
withdrawal (n=36) p=0.059* 
Passive/ Apathetic 2.06 2.32 -0.3333 -1.560 
Social withdrawal p=0.128 
(n=36) 
Difficulty in 3.15 3.61 -0.5139 -3.667 
abstract thinking p=O.OOl *** 
(n=36) 
Stereotyped 1.69 1.82 -0.2361 -1.738 
Thinking (n=36) p=0.091 * 
Anxiety (n=36) 1.71 1.84 -0.1667 -1.456 
p=O.l54 
Guilt Feelings 1.38 1.42 -0.0833 -0.770 
(n=36) p=0.446 
Depression (n=36) 1.50 1.29 0.0417 0.407 
p=0.686 
Unusual Thought 1.68 1.87 -0.2778 -1.890 
Content (n=36) p=0.067* 
Disorientation 1.10 1.08 0.0139 0.239 
(n=36) p=0.812 
Poor attention 1.53 1.50 -0.0417 -0.424 
(n=35) p=0.674 
Lack of judgment 1.99 1.87 -0.0694 -0.492 
and insight (n-36) p=0.626 
Disturbance of 1.56 1.55 -0.0972 -1.156 
Volition (n=36) p=0.255 
Active social 1.43 1.32 0.0833 0.882 
avoidance (n=36) p=0.384 
Severity of the 2.16 2.38 -0.2059 -0.929 
Illness (n=34) p=0.359 
Global 1.45 1.61 -0.2206 -1.460 
Improvement p=0.154 
(n=34) 
Depressed Mood 0.29 0.18 0.1000 1.871 
(n=35) p=0.070* 
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Hopelessness 0.10 0.08 -0.0429 -0.828 
(n=35) p=0.413 
Self-Depreciation 0.27 0.37 -0.2143 -2.266 
(n=35) p=0.03** 
Suicide (n=35) 0.06 0.00 0.0286 1.000 
p=0.324 
Apparent Sadness 0.33 0.42 -0.2286 -1.876 
(n=35) p=0.069* 
Reduced Sleep 0.16 0.13 -0.0857 -1.358 
(n=35) p=0.183 
Concentration 0.94 0.89 -0.2571 -1.417 
Difficulties p=0.166 
(n=35) 
Lassitude (n=35) 0.70 0.82 -0.3143 -2.283 
p=0.029** 
Inability to feel 0.53 0.74 -0.3571 -2.152 
(n=35) p=0.039** 
Pessimistic 0.69 0.50 0.0714 0.487 
Thoughts (n=35) p=0.629 
Suicidal Thoughts 0.21 0.24 -0.1714 -0.973 
(n=35) p=0.338 
Sleep (n=35) 0.15 0.05 0.0286 0.529 
p=0.600 
Irritability (n=28) 0.49 0.40 -0.1607 -1.000 
p=0.326 
Speech (n=38) 0.13 0.18 0.000 0.000 
p=1.000 
Language (n=35) 0.20 0.16 0.0714 0.776 
p=0.443 
Content (n=62) 0.32 0.79 3.7742 6.018 
p=O.OOO*** 
Disruptive 0.20 -6.69 -0.0143 -0.215 
Behaviour (n=62) p=0.831 
Insight (n=35) 0.31 0.68 -0.3857 -2.232 
p=0.032** 
Alcohol Use 1.02 1.13 -0.1351 -1.221 
(n=37) p=0.230 
Cannibinoids Use 0.67 0.68 -0.1081 -1.000 
(n=37) p=0.324 
Cocaine Use 0.03 0.00 0.0000 0 
(n=37) 
Hallucinogens 0.03 0.00 0.0000 0 
Use (n=37) 
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Social Activity 3.91 4.16 0.3056 1.768 
(n=36) p=0.086* 
Social Network 3.82 3.97 0.2500 1.505 
(n=36) p=0.141 
Social withdrawal 4.09 4.19 0.3333 1.394 
(n=36) p=0.172 
Sociosexual 2.79 2.86 0.3333 1.394 
relations (n=36) p=0.172 
Extent ofQOL 3.79 3.49 -0.0278 -0.122 
(n=36) p=0.903 
Adequacy ofQOL 3.59 3.57 0.1111 0.572 
(n=36) p=0.571 
Underemployment 3.83 3.84 0.1111 0.520 
(n=36) p=0.606 
Sense of 3.95 4.53 0.2069 1.063 
purpose(n=36) p=0.297 
Motivation (n=36) 4.12 4.35 0.1111 0.681 
p=0.500 
Time Utilization 4.44 4.35 -0.1389 0.695 
(n=36) p=0.492 
Activities (n=36) 4.71 4.70 0.2778 1.056 
p=0.298 
ESRS 1.20 1.13 -0.0147 -0.215 
Restlessness p=0.831 
(n=34) 
BAS objective 0.11 0.10 0.0000 0.000 
(n=35) p=1.000 
BAS subjective 0.16 0.15 0.0000 0.000 
(awareness of p=l.OOO 
restlessness) 
(n=35) 
Distress related to 0.05 0.10 -0.0571 -0.813 
restlessness p=0.422 
(n=35) 
p::;-0. OJ*** p::;-0. 05 ** p::;-0.1 0* 
The results for the treatment effects on school and employment for the patients 
from entry to two years are presented in Table 10. This study found significant 
improvements (ps 0.01) over two years in the program on employment, but there was no 
statistically significant improvement (p20.1 0) in attending school. 
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Table 10. Pre-Post treatment results between 0-24months on School, 
E I d R "t I" fi P . mp1 oyment an ospl a 1zatwns or at1ents 
VARIABLE MEAN MEAN(24 MEAN t-value 
(INITIAL) MONTHS) DIFFERENCE 
School (n=88) 1.65 1.67 -0.0341 -0.623 
p=0.535 
Employment 1.76 1.60 0.2000 4.279 
(n=95) p=O.OOO*** 
p50.01 *** p50.05** p50.10* 
4.3 Results from Benchmarking Early Psychosis Patients with CCHS 
Atlantic Population 
During this analysis, the NL early psychosis patients are matched with the CCHS 
population. From the 120 patients, 97 patients are between the ages of 15-29 and are 
benchmarked with the 15-29-age population from CCHS Atlantic Canada. They are 
assessed on several scale variables at entry. The 97 patients are then match~d on the 
various variables at two years into the program, using the 15-34-age range of CCHS 
Atlantic Canada population. Independent-Sample t-tests are used for the analyses. 
The results for the group difference on the variables at entry are presented in 
Table 11. This study found significant differences (p~ 0.01) between the NL patients and 
the CCHS population at entry on passive/apathetic withdrawal, mental health status, 
depression, suicidal thoughts, suicidal attempt, lassitude, reduced sleep, irritability, 
drinking despite health problem (alcohol), cannibinoids use, friends, activities, 
interaction, social network, social activity, distress related to restlessness hospitalization. 
There are significant differences (p~ 0.1 0) between the groups on the 
concentration difficulty variable. 
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There are no significant differences (p2:: 0.1 0) between the groups on pessimistic 
thoughts, sleep, alcohol, cocaine and hallucinogen use, restlessness, attending school and 
employment. 
Table 11. Results from Benchmarking Early Psychosis Patients with CCHS 
A I . P I t" t h (15 29 ) t antzc opu a wn at en ry mto t e program - years 
Variable EPP EPP CCHS CCHS t-value at 
initial initial initial initial initiation 
mean standard mean standard 
deviation deviation 
Passive/ Apathetic 1.35 0.480 1.96 0.196 -25.617 
social withdrawal (n=94) (n=1453) p=O.OOO*** 
Mental health 4.16 1.079 2.14 0.939 20.178 
(severity of the (n=96) (n=1458) p=O.OOO*** 
illness) 
Depressive 1.48 0.502 1.21 0.405 4.741 
Symptoms (n=82) (n=200) p=O.OOO*** 
Suicidal thoughts 1.79 0.412 1.62 0.487 2.725 
(n=89) (n=155) p=0.007*** 
Suicidal attempt 1.79 0.412 1.96 0.196 -7.411 
(n=89) (n=1450) p=O.OOO*** 
Reduced Sleep 1.47 0.504 1.27 0.446 2.629 
(n=49) (n=155) p=0.009*** 
Sleep 1.47 0.504 1.46 0.500 0.1000 
(n=49) (n=247) p=0.920 
Concentration 1.27 0.446 1.17 0.375 1.913 
difficulties (n=93) (n=155) p=0.057* 
Pessimistic 1.31 0.468 1.34 0.476 -0.329 
Thoughts (n=48) (n=109) p=0.743 
Lassitude 1.43 0.500 2.08 0.955 -4.571 
(n=49) {n=149) p=O.OOO*** 
Irritability 1.35 0.479 1.57 0.501 -2.495 
(n=95) (n=46) p=0.014*** 
Alcohol Use 1.23 0.423 1.19 0.396 0.835 
(n=96) (n=1452) p=0.404 
Drink despite 1.23 0.423 1.94 0.246 -22.228 
health problem {n=96) (n=466) p=O.OOO*** 
Cannibinoids Use 1.31 0.466 1.52 0.500 -3.903 
(n=96) (n=809) p=O.OOO*** 
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Cocaine Use 1.86 0.344 1.78 0.420 1.474 
(n=96) (n=67) p=0.142 
Hallucinogen 1.81 0.392 1.84 0.366 -0.616 
Use (n=96) (n=177) p=0.538 
Friends 1.21 0.408 1.98 0.122 -47.312 
(n=96) (n=1452) p=O.OOO*** 
Activities 2.26 0.617 2.69 0.687 -5.980 
(n=97) (n=1452) p=O.OOO*** 
Interaction 1.96 0.776 3.66 0.662 -24.256 
(n=97) (n=1436) p=O.OOO*** 
Social Network 1.42 0.775 3.63 0.722 -28.960 
(n=97) (n=1437) p=O.OOO*** 
Social Activity 1.29 0.763 3.58 0.714 -30.524 
(n=97) (n=l437) p=O.OOO*** 
Restlessness 1.33 0.562 1.46 0.820 -1.511 
(n=86) (n=1453) p=0.131 
Distress related 0.08 0.312 0.46 0.820 -4.523 
to restlessness (n=97) (n=1453) p=O.OOO*** 
School 1.65 0.481 162 0.592 0.394 
(n=96) (n=l461) p=0.693 
Employment 1.76 0.429 1.73 0.982 0.292 
(n=96) (n=1461) p=0.771 
Hospitalization 1.33 0.473 5.93 0.570 -77.764 
(n=97) (n=1461) p=O.OOO*** 
p50.01*** p50.05** p50.10* 
The results for the group differences on the variables at two years to see if the NL 
patient group converges back to the population are presented in Table 12. This study 
found no significant differences (p~ 0.1 0) between the NL patients and the CCHS 
population to suggesting convergence after two years on suicide, pessimistic thoughts, 
irritability, cannibinoids use; attending school and employment. 
There are four variables: mental health, lassitude, alcohol use, and hospitalization 
that show convergence for the NL group after two years, by looking at the decreasing t-
values, although they are statistically significant. 
There are statistically significant group differences (p::; 0.01), (p::; 0.05) and 
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(p~ 0.10) on the rest ofthe variables, suggesting no convergence. 
Table 12. Results .from Benchmarking Early Psychosis Patients with CCHS 
Atlantic Population Two years into the program (15-34 years) 
Variable EPP 24 EPP 24 CCHS CCHS 24 t-value at 
Passive/ Apathetic 
social withdrawal 
Mental health 
(Severity of the 
illness) 
Depressive 
Symptoms 
Suicidal thoughts 
Suicide 
Reduced Sleep 
Sleep 
Concentration 
difficulties 
Pessimistic 
Thoughts 
Lassitude 
Irritability 
Alcohol Use 
Drink despite 
health problem 
Cannibinoids Use 
Cocaine Use 
Hallucinogens 
Use 
Friends 
month month 24 month 24 months 
mean standard month standard 
1.03 
(n=58) 
2.41 
(n=64) 
1.68 
(n=41) 
1.98 
(n=41) 
1.98 
(n=41) 
1.93 
(n=56) 
1.82 
(n=56) 
1.63 
(n=59) 
1.46 
(n=60) 
1.48 
(n=56) 
1.65 
(n=56) 
1.32 
(n=59) 
1.32 
(n=59) 
1.63 
(n=59) 
1.98 
(n=59) 
1.98 
(n=59) 
1.06 
(n=47) 
deviation 
0.158 
1.207 
0.264 
0.156 
0.156 
0.260 
0.260 
0.488 
0.539 
0.556 
0.485 
0.471 
0.471 
0.488 
0.130 
0.130 
0.247 
mean 
1.96 
(n=2072) 
2.12 
(n=2072) 
1.18 
(n=301) 
1.25 
(n=242) 
1.96 
(n=2067) 
1.25 
(n=241) 
1.46 
(n=318) 
1.15 
(n=243) 
1.34 
{n=166) 
2.05 
(n=235) 
1.51 
(n=59) 
1.17 
(n=2071) 
1.94 
(n=645) 
1.59 
(n=1176) 
1.83 
(n=118) 
1.88 
(n=262) 
1.99 
(n=2071) 
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deviation 
0.190 
0.903 
0.384 
0.156 
0.194 
0.433 
0.499 
0.360 
0.475 
0.990 
0.504 
0.380 
0.236 
0.492 
0.377 
0.328 
0.118 
-36.760 
p=O.OOO*** 
2.509 
p=0.012*** 
7.647 
p=O.OOO*** 
10.638 
p=O.OOO*** 
0.485 
p=0.628 
11.266 
_p=O.OOO*** 
5.167 
p=O.OOO*** 
8.433 
p=O.OOO*** 
1.632 
p=0.104 
-4.144 
p=O.OOO*** 
1.551 
p=0.124 
2.914 
p=0.004*** 
-17.290 
p=O.OOO*** 
0.525 
p=0.600 
3.017 
p=0.003*** 
2.418 
p=0.016** 
-51.317 
p=O.OOO*** 
Activities 2.41 0.561 2.69 0.680 -3.148 
(n=59) (n=2071) p=0.002*** 
Interaction 3.00 1.043 3.64 0.685 -6.232 
(n=47) (n=2053) p=O.OOO*** 
Social Network 2.12 0.646 3.61 0.736 -15.359 
(n=59) (n=2054) p=O.OOO*** 
Social Activity 2.10 0.548 3.55 0.733 -15.088 
(n=59) (n=2054) p=O.OOO*** 
Distress related 0.05 0.227 0.96 0.952 -7.089 
to restlessness (n=56) (n=2072) p=O.OOO*** 
Restlessness 1.22 0.526 1.43 0.800 -2.016 
(n=57) (n=2072) p=0.044** 
School 1.67 0.473 1.72 0.532 -0.837 
(n=88) (n=2073) p=0.402 
Employment 1.60 0.493 1.65 0.906 -0.528 
(n=85) (n=2073) p=0.598 
Hospitalization 1.90 0.299 5.92 0.595 -64.434 
(n=92) (n=2073) p=O.OOO*** 
pSO.Ol*** pS0.05** pSO.JO* 
4.4 Results from matching Early Psychosis Patients with CCHS 
Population with Psychosis 
============================================= 
During this analysis, the NL early psychosis patients are matched with the CCHS 
population who had psychosis and followed the age-criteria of 15-29 years and 15-34 
years. From the 120 NL early psychosis patients, 97 patients are between the ages of 15-
29 and are used to match with the 15-29-age CCHS psychotic population. They are 
assessed on several scale variables at entry. The 97 patients are then matched on the 
various variables at two years into the program, using the 15-34-age psychotic CCHS 
population. The differences in the trajectories calculated at this point are then 
differenced to determine NL Program treatment effects. Difference of differences t-tests 
90 
(inference about the difference between two means when there are independent samples) 
is used for the analyses. 
The results are presented in Table 13. This study found significant differences 
(t ~ 0.01) to show a NL Program effect on the following variables: passive/apathetic 
social withdrawal, mental health status, suicidal thoughts, suicide attempt, concentration 
difficulties, reduced sleep, sleep, cannibinoids and hallucinogens use, interaction, social 
network, social activity, restlessness, distress related to restlessness, attending school and 
hospitalization. 
There is statistical significant treatment effects at t ~ 0.05 for depressive 
symptoms; and statistical significant treatment effects at t ~ 0.10 for cocaine use, friends 
and employment. 
There are no statistical significant NL Program effects (t ::;; 0.1 0) on pessimistic 
thoughts, lassitude, irritability, alcohol use and drinking despite health problems. 
Table 13. Results from Propensity Matching Early Psychosis Patients with CCHS 
P l . if h S A dWh H P h . opu atwn o t e a me ge an 0 as syc oszs 
Variable EPP EPP CCHS CCHS CCHS CCHS Pooled t-value 
diff diff initial initial 24month 24rnonth s.d. 
mean s.d mean s.d. mean s.d. 
Passive/ -0.2184 0.4492 1.74 0.442 1.68 0.190 0.3133 -5.285"'** 
Apathetic (n=87) (n=84) (n=131) 
Social 
Withdrawal 
Mental health -1.1139 1.7817 3.81 0.963 3.70 0.903 0.9267 -6.503*** 
(n=10) (n=84) (n=132) 
Depressive 0.1622 0.5535 1.06 0.240 1.06 0.239 0.2394 1.747** 
Symptoms (n=37) (n=66) (n=100) 
Suicidal 0.2195 0.4750 1.44 0.500 1.42 0.496 0.4976 2.368*** 
thoughts (n=41) (n=62) (n=93) 
Suicide 0.1549 0.4358 1.57 0.498 162 0.194 0.3458 3.605*** 
(n=71) (n=84) (n=131) 
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Reduced Sleep 0.4643 0.5049 1.23 0.422 1.23 0.433 0.4285 5.665*** 
(n=46) (n=66) (n=93) 
Sleep 0.4872 0.5064 1.22 0.417 1.20 0.403 0.4086 5.219*** 
(n=39) (n=46) (n=70) 
Concentration 0.3393 0.6113 1.65 0.493 1.60 0.503 0.4985 2.500*** 
difficulties (n=56) (n=17) (n=20) 
Pessimistic -0.0952 0.6446 1.24 0.435 1.26 0.444 0.4406 -0.499 
Thoughts (n=21) (n=45) (n=72) 
Lassitude 0.0488 0.7567 1.68 0.919 1.68 0.990 0.9936 0.3422 
(n=41) (n=62) (n=93) 
Irritability 0.2909 0.6360 1.75 0.500 1.75 0.504 1.7500 0.4657 
(n=55) (n=4) (n=4) 
Alcohol Use 0.0674 0.4954 1.24 0.428 1.23 0.380 0.3993 0.9709 
(n=89) (n=84) (n=132) 
Drink despite 0.1311 0.5315 1.70 0.466 1.58 0.236 0.3559 0.1377 
health problem (n=61) (n=30) (n=38) 
Cannibinoids 0.2923 0.6306 1.38 0.488 1.48 0.492 0.4905 4.510*** 
Use (n=65) (n=64) (n=102) 
Cocaine Use 0.0678 0.3143 1.67 0.482 1.70 0.377 0.4190 1.471 * 
(n=59) (n=24) (n=40) 
Hallucinogens 0.1864 0.4345 1.73 0.450 1.77 0.328 0.3819 3.149*** 
(n=59) (n=30) (n=44) 
Friends -0.1169 0.3965 1.83 0.375 1.79 0.118 0.2516 1.591* 
(n=77) (n=84) (n=l31) 
Activities 0.0562 0.8442 1.99 0.885 1.99 0.680 0.7664 0.5425 
(n=89) (n=84) (n=l31) 
Interaction 0.4342 1.2570 1.25 0.783 3.06 0.685 0.7246 14.687*** 
(n=76) (n=81) (n=127) 
Social Network 0.2386 1.2317 1.38 0.734 3.24 0.736 0.7352 14.905*** 
(n=88) (n=81) (n=127) 
Social Activity 0.4205 1.1519 1.26 0.803 2.99 0.733 0.7609 16.091 *** 
(n=88) (n=81) (n=127) 
Restlessness 0.5543 0.7880 2.86 1.466 2.14 1.106 1.5823 -1.080 * 
(n=52) (n=84) (n=132) 
Distress related 0.2209 0.8029 2.57 1.056 1.80 0.952 0.9936 -4.999*** 
to restlessness (n=86) (n=84) (n=l32) 
School 0.0341 0.5130 1.64 0.483 1.85 1.025 0.8498 3.029*** 
(n=88) (n=83) (n=123) 
Employment -0.2000 0.4309 1.75 0.437 1.83 1.248 0.9608 -1.463* 
(n=85) (n=83) (n=l20) 
Hospitalization 0.5543 0.5419 1.31 0.465 3.03 1.856 1.4706 19.616*** 
(n=92) (n=84) (n=127) 
t :?0.01*** !:?0.05* !:?0.10* 
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CHAPTERS 
DISCUSSION 
5.1 Pre-Post Findings on Patient Assessment Scales 
The first objective of this study was to evaluate the impact of the NL Program 
for patients on a number of clinical and social outcomes. This was done by first 
performing the pre-post methodology and secondly, by performing the propensity 
matching methodology, which will be described in section 5.4. 
The pre-post analysis was done on the patients over three years by first 
assessing the eight scales and then assessing the variables within each scale, which 
will be discussed in section 5 .2. Researchers when evaluating early psychosis 
programs typically use this pre-post methodology (Addington et al., 2004b; & Malia 
et al., 2001). 
The results of the pre-post analysis on patient performances on the multiple 
clinical scales found significant improvements for patients within the first year of the 
NL Program on seven scales: PANSS, GAS, The Calgary Depression Scale, 
MADRS, YMRS, The Case Managers Substance Use Disorder scale, and the Quality 
of Life scale. In the second year, patients show improvement on only two scales, 
MADRS and YMRS. There are no significant improvements in the third year. This 
suggests that the NL Program is having a major treatment effect within the first 12 
months. This may be due to the fact that patients are regulated on their medication 
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during the first year and this is maintained during the rest of their program treatment. 
As well, patients are receiving psychosocial treatments. A significant improvement 
on the MADRS and YMRS scales again in the second year, suggests that it may take 
two years for patients to improve in mood symptom clusters. 
5.2 Pre-Post Findings on Variables Within The Scales 
The pre-post analysis on patient performances on various scales variables was 
also done over three years, with assessments made at 12, 24 and 36 months. 
On the PANSS, patients show improvement on all scale variables (delusions, 
hallucinatory behaviour, suspiciousness, emotional withdrawal, passive/apathetic 
social withdrawal, difficulty in abstract thinking, stereotyped thinking, anxiety, guilt 
feelings, depression, unusual thought content, disorientation, poor attention, lack of 
judgment and insight, disturbance of volition and active social avoidance) over the 
first year. In the second year, patients improve on difficulty in abstract thinking and 
poor attention variables. In the third year, patients improve on emotional withdrawal, 
difficulty in abstract thinking, stereotyped thinking and unusual thought content 
variable. These results suggest that the NL Program has a major treatment effect on 
reducing psychotic symptoms within the first year of the program. The patients 
continue to improve on the difficulty in abstract thinking variable during the entire 
program, suggesting that this variable improvement requires a longer treatment 
period. The NL Program also seems to improve poor attention, emotional 
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withdrawal, stereotyped thinking and unusual thought content variables longer than 
the first year. 
On the COl scale, the patients show improvement during the first year on the 
severity of the illness variable. In the second year and third year, there were no 
significant treatment effects on severity of the illness or global improvement 
variables. These results suggest that the NL Program has an overall effect on the 
patients during the first year. 
On The Calgary Depression Scale, patients significantly improve on all 
variables (depressed mood, hopelessness, and suicide), except for self-depreciation 
variable during the first year. In the second year, there are no significant 
improvements on any of this scale's variables. In the third year, there are significant 
treatment improvements in depressed mood and self-depreciation variables. These 
findings suggest that the NL Program continually improves patients on depression 
throughout the program and has a major effect on self-depreciation by the third year. 
On the MADRS, most variables (apparent sadness, reduced sleep, 
concentration difficulties, pessimistic thoughts and suicidal thoughts) show 
significant patient improvement during the first year, except for the lassitude and 
inability to feel variables. In the second year, patients continue to significantly 
improve on concentration and pessimistic thoughts variables. In the third year, 
patients improve on apparent sadness, lassitude and inability to feel variables. These 
findings suggest that it takes at least two years for the NL Program to help patients 
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with concentration difficulties and pessimistic thoughts, and at least three years for 
patients to improve on lassitude and inability to feel. 
On the YMRS, all variables (sleep, irritability, speech, language, content, 
disruptive behaviour and insight) analyzed show patient improvement within the first 
year. During the second year, patients only show significant improvement in the 
content variable. In the third year, there are also improvements in the content 
variable as well as the insight variable. Since the NL Program offers psychotherapy 
and psychoeducation, the program continues to improve patient insight about having 
an illness. 
On The Case Managers Rating Scale for Substance Use Disorder, patients 
demonstrate significant improvement on all scale variables (alcohol, cannibinoids and 
hallucinogen use) assessed during the first year. There are no significant 
improvements on any of these variables during the second and third year of the 
program. This suggests that the NL Program is successful in addressing substance 
misuse and its consequences within the first year ofthe program. 
On the Quality of Life scale, patients demonstrate significant improvements 
on all variables (social activity, social network, social withdrawal, sociosexual 
relations, extent of quality of life, adequacy of quality of life, underemployment, 
sense of purpose, motivation, time utilization and activities) during their first year. In 
the second year, there are no significant improvements on any of the scales. In the 
third year, there is significant improvement on the social activity variable. These 
findings suggest that the NL Program significantly helps patients with social 
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outcomes during their first year of the program, through their therapy support groups 
and recreational therapy that provides social activities. 
On the BAS, patients only show improvement for the objective variable in the 
second year. There are no patient improvements on the subjective and distress related 
to restlessness variables. 
On the ESRS, only one variable, restlessness is assessed. In all three years, 
the patients did not improve on this variable. These results coincide with the results 
found on distress related to restlessness from the BAS. Restlessness is a common 
side effect from taking psychotic medication. This may explain why patients appear 
to be restless during the three years in the program. 
The pre-post results evaluate school and employment on a two-year 
assessment because there are no specific scales used by the NL program to request 
this information on one-year follow-ups. The results found significant improvements 
in employment after two years, suggesting that many patients have entered or 
reentered the workforce at the end of two years. Since there were no improvements 
in schooling at the end of two years, one may speculate that this maybe a result of 
patients graduating and entering into the workforce. 
Therefore, using the traditional pre-post methodology, it can be concluded that 
the NL program has had a significant impact for patients on a number of clinical and 
social outcomes. 
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5.3 Benchmarking Findings 
The benchmarking exercise was done to compare the NL early psychosis 
patients to the Canadian population to see how they perform on clinical and social 
outcomes at entry into the program and then at two years later. If the patients 
converge back towards the population at the end of two years, it suggests the NL 
Program is effective in helping patients to recover and rehabilitate. 
The national population was taken from the CCHS that was completed by a 
random sample of families across Canada. It was decided to benchmark the patients 
to the CCHS population from the Atlantic region and who are of the same age. Since 
early psychosis programs are typically designed for 15-29 year olds, this was the age 
criterion for the patients and the CCHS population at initiation. Since the NL patients 
will have increased in age by two years, the second CCHS cohort was taken by 
increasing the age range from 30-34 years, the next interval in the age category of the 
survey. 
To compare the patients to the CCHS population, variables from the various 
scales were matched as accurately as possible to several questions asked in the survey 
(See Appendix G for reference). In total, 26 variables from the Early Psychosis 
scales were matched with 26 questions from CCHS. 
The results illustrate a significant difference at entry between the NL patients 
and the population on the passive/apathetic social withdrawal variable. At the end of 
the two years, the patients also show a significant difference on the passive/apathetic 
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social withdrawal variable compared to the population, therefore suggesting no 
convergence towards the population after 2 years. 
At entry and at two years, there is a significant difference between the groups 
on the mental health variable (severity of the illness) variable. However, the t-value 
appears to be decreasing, therefore suggesting the patients are showing a trend of 
convergence towards the population. 
The results indicate that at entry, the groups differ on the depressed 
symptoms, suicidal thoughts and suicidal attempt variables. At two years, there was a 
significant difference between the groups on depressed mood and suicidal thoughts. 
However, at two years, there was no difference between the groups on suicidal 
attempts, suggesting the NL patients are converging towards the population on this 
variable. 
At entry, the groups differ on concentration difficulties, lassitude and reduced 
sleep, but there is no difference between the groups on pessimistic thoughts and sleep. 
At the end of two years into the program, the patients differ from the population on 
reduced sleep, sleep, concentration difficulties and lassitude variables. They did not 
differ from the group on pessimistic thoughts, suggesting convergence towards the 
population on this variable. As well, the decreasing t-value for the lassitude variable 
suggests that the patients are showing a trend of convergence towards the population 
in lassitude. 
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The results indicate the patients did differ from the group at entry on 
irritability, but at the end ofthe two years they converged towards the population on 
this variable. 
At entry, the patients differ from the population on the drinking despite health 
problem and the cannibinoids use variables. At the end of the two years, the groups 
differ on alcohol use, drinking despite health problems, cocaine and hallucinogen use 
variables. The patients only converge towards the population on using cannibinoids. 
However, comparing the t-values from entry to two years on the alcohol variable, the 
results illustrate a decreasing t-value. Thus, patients maybe converging towards the 
population on alcohol use. 
The results indicate that the patients did differ from the population at entry 
and then again at two years, to suggest the NL patients did not converge towards the 
population on the social activity, social network, interaction, friends and activities 
variables. 
There is a difference between the groups at entry and then again after two 
years on the distress related to restlessness variable. Therefore, there was no 
convergence on this variable. 
The patients did not differ from the population at entry, but did differ from the 
population at two years on the restless variable. Thus, the patients diverge from the 
population on this variable. This is the only condition where deterioration occurred. 
This may be a result of patients taking psychotic medication, which may have a side 
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effect of restlessness. Since the patients on all other variables stayed the same or 
converge, the restless variable may require further investigation. 
At entry, the patients did not differ from the population on school and 
employment. At the end of the two years, no difference was found between the two 
groups on these variables, suggesting the patients converge towards the population. 
The patients, however, did differ from the population at entry and at two years on the 
hospitalization for mental health variable. However, the t-value appeared to be 
decreasing, thus suggesting convergence on the hospitalization variable. 
Thus, overall, this benchmarking exercise shows that patients are converging 
towards the population on irritability, pessimistic thoughts and suicidal attempt. It 
also shows that the NL patients are converging towards the population on 
cannibinoids use, school and employment issues. Although not statistically 
significant, there seems to be some evidence of convergence on the mental health, 
lassitude, alcohol and hospitalization variables. Patient improvement on these four 
variables may prove to be significant beyond two years of treatment. 
5.4 Propensity Matching Findings 
One of the main purposes of this thesis is to test a new methodology-
propensity matching-on a unique group, in which randomization and comparing to a 
control group is difficult, and pre-post methodology must be used with limitations 
since there are no control groups used and maturation maybe the cause of the pre-post 
changes. 
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To perform the propensity matching methodology, the NL early psychosis 
patients were matched to the CCHS population on various characteristics to 
determine a NL Program treatment effect. The criterion used to match the NL 
patients with the population was that the population had to have psychosis and was of 
the same age. Unfortunately, the CCHS population was very limited in the number of 
people who had psychosis ( 411 psychotic people). Therefore, propensity matching 
by matching on demographics as described by Ascher-Svanum et al. (2003) could not 
be performed in this analysis. However, propensity matching to show a NL Program 
effect can be performed by first, comparing the patients and the population at entry 
and then at two years on the various variables to determine the trajectories, and then 
differencing the trajectories of the patients on these variables to determine the NL 
Program treatment effects. This meets the study's objectives 2-5. 
Therefore, in evaluating the NL Program using propensity matching, there are 
significant program effects found at the end of the two years on several variables. 
There are significant NL Program effects on the passive/apathetic social 
withdrawal variable. 
There are significant improvements in mental health over two years. 
The NL Program is having a treatment effect on depressive symptoms, 
suicidal thoughts and suicidal attempt. 
There are significant NL Program treatment effects on reduced sleep, sleep 
and concentration difficulties variables. However, propensity matching found no 
program effects on pessimistic thoughts and lassitude variables. 
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There is no significant program effect for reducing irritability. 
There are significant NL Program effects over two years on cannibinoids, 
cocaine and hallucinogen use variables. However, patients show no significant 
improvements on alcohol use or drinking despite health problem variables. 
There are significant program treatment effects on friends, interaction, social 
network and social activity. However, there is no program effect at two years on the 
activities variable. 
The NL Program helps patients improve significantly on the distress related to 
restlessness variable and on the restlessness variable. 
Also, there is significant NL Program treatment effects found on the school, 
employment and hospitalizations variables at the end of the two years. 
Therefore, overall, comparing patients to the general population who has 
psychosis using propensity matching, the results found the NL Program is having a 
major impact on improving patients on a number of clinical and social outcomes. 
Thus, this methodology, despite its limitations, can be used to evaluate early 
psychosis programs. 
5.5 Pre-Post versus Propensity Matching Findings 
Objective 6 of this thesis is to compare and contrast propensity matching with 
the traditional pre-post methodology, to determine if propensity matching can be used 
as an alternative method to show the treatment effect of early psychosis programs. 
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The variables compared upon in this section are only the variables that could be used 
in the propensity matching section. 
On the P ANSS, the pre-post methodology found patients show significant 
improvement on the social/apathetic social withdrawal variable during the first year. 
Propensity matching also found the same results for this variable, therefore 
suggesting that the NL Program reduces symptoms for its patients. 
On the CGI scale, pre-post methodology shows patient improvement on the 
severity of the illness variable during the first year. Similar results were found using 
propensity matching. 
On the Calgary Depression scale, there were significant improvements on the 
scale and the suicide variable within the first year using the pre-post methodology. 
These findings were also found using propensity matching. 
On the MADRS, using the pre-post, patients show significant improvements 
on reduced sleep in the first year; significant improvements on the concentration 
difficulties, pessimistic thoughts and suicidal thoughts variables in the first and 
second years; and significant improvements in the lassitude variable by the third year. 
The propensity matching method found significant improvements for patients on 
reduced sleep and concentration difficulties variables after two years in the program. 
Since the lassitude variable took three years to show improvement using the pre-post, 
this may explain why there was no significant improvement on lassitude using 
propensity matching after 2 years. 
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On the YMRS, patients show significant improvement on the irritability 
variable in the first year using the pre-post. However, propensity matching show no 
significant program effect after two years. 
On The Case Manager's Rating Scale for Substance Use Disorder, the pre-
post methodology found patients show significant improvement on the scale variables 
(alcohol, cannibinoids and hallucinogen use) in the first year. There are significant 
program effects on cannibinoids, cocaine and hallucinogen use after two years in the 
program using propensity matching. 
On the Quality of Life Scale, the pre-post methodology found patients show 
significant improvements on all the variables (social activity, social network and 
activities) during the first year and continue significant improvement on the social 
activity variable by the third year. The propensity matching methodology found there 
are significant program effects on social network and social activity at the end of the 
two years. Therefore, the results are similar to the pre-post suggesting the NL 
Program is helping patients with improving their quality of life. 
On the BAS, there are no significant improvements on the distress variable 
using the pre-post methodology. However, propensity matching did find a significant 
program effect on this variable. 
On the ESRS variable, the pre-post show no significant improvement for 
patients on the restlessness variable. However, propensity matching methodology did 
find a significant improvement on this variable over two years. This variable may 
require further investigation. 
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The pre-post methodology found significant improvement on employment for 
patients after two years. Propensity matching also found the same results for 
employment as well as the school and hospitalization variable. 
Overall, both methodologies show NL Program treatment effects on 
social/apathetic social withdrawal; severity of the illness; depressive symptoms; 
suicide; reduced sleep; concentration difficulties; cannibinoids, cocaine and 
hallucinogen use; social activity and social network; employment and hospitalization 
variables. 
There are relative strength and weaknesses of using either the pre-post or 
propensity matching methodology to evaluate an early psychosis program. See 
Table 14 for a comparison between the two methodologies. 
Table 14. Comparison of Pre-Post versus Propensity Matching Methodology to 
El ElP h"P va uate ary syc OSlS rograms 
PRE-POST PROPENSITY 
MATCHING 
STRENGTHS 1. Easy to perform 1. Assumes the effects 
2. Limited time of RCT synthetic 
required to control group i.e. 
perform Individuals are 
3. No issue of randomly selected 
matching and no baseline 
questions differences between 
4. Evaluator has groups 
control over the 2. Confounding effects 
questions asked are taken into 
5. Data is reliable account 
WEAKNESSES 1. Potentially 1. More challenging to 
misleading if perform 
confounding 2. Time consuming 
effects are taken 3. Difficulty in finding 
into account a representative 
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2. No control group population to match 
used the Early Psychosis 
Program 
4. Timing issue of the 
data used to compare 
with the program i.e. 
The date the 
population data was 
collected and 
published 
5. Evaluator is unaware 
of other treatments 
the population 
may/may not have 
received that may 
alter the results 
Therefore, it can be concluded from this research that propensity matching 
methodology offers a new way to evaluate early psychosis programs to determine 
social and clinical outcomes. 
5.6 Comparison of Study's Findings to Previous Studies 
This study's results from the PANSS scale are similar to those found by 
Addington et al. (2003). The NL patients improve on all positive and negative 
symptom variables examined over the first year. This suggests that the NL Program 
helps to reduce symptoms, possibly by getting patients regulated on the appropriate 
medication within the first year. This is suggested since this study found a decrease 
in hospitalization rates over two years. 
This study's results on the Quality of Life Scale are similar to Malia et al. 
(2003) and Addington et al. (2003) whose evaluations oftheir programs found 
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improvements in quality of life. This study's patients significantly improve in social 
functioning during the first year on variables such as social activity, social network, 
social withdrawal, extent of quality of life, adequacy of quality of life, sense of 
purpose and motivation. After two years into the NL Program, patients also show an 
improvement in employment outcomes. The propensity matching methodology also 
show an improvement in schooling after two years. Therefore, the NL Program's 
occupational therapy appears to be helping patients recover and encouraging them to 
complete or continue their education and integrate into the workforce, thus providing 
hope for the future. Newstead & Kelly (2002) state that society may also benefit in 
time for socially including this group within society since it may provide 
opportunities to form partnerships with the patients and carers to facilitate a greater 
understanding of differing value and move towards a common set of principles 
regarding mental health care. 
Sorbara et al. (2003) investigated the impact of substance and alcohol misuse 
on clinical and social outcomes over two years and found persistent substance misuse 
had a detrimental impact on clinical outcome. This study found a decrease in alcohol 
and substance misuse by the patients, suggesting that the NL Program's substance use 
prevention counseling is effective and may have been a factor in why there was 
significant clinical outcome improvement. This is important since there has been 
extensive evidence that suggests substance use, especially cannabis use, is a risk 
factor for psychotic symptoms (Sorbara et al., 2003). 
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This study also found the severity of the illness on CGI decreased with 
treatment. Therefore, confirming previous studies by McGorry (2000a), and 
McGlashan and Johannessen (1996) that reducing DUP at the earliest possible time 
and providing early treatment is important. 
This study found patients improve on YMRS insight variable and PANSS lack 
of judgment and insight variable during the first year into the program to suggest that 
the program's individual and group therapies helped patients realize that they have a 
mental disorder and that they need treatment. Mintz et al. (2004) also found insight 
improved for their Calgary patients during the first year of the program. 
Program treatment effects are reported on the Calgary Depression Scale for 
reducing depression. Depression plays a major role in psychotic illness, since 
patients may feel alienated and lose self-esteem when there is a major change in their 
life (Jackson & lqbalt, 2000). Therefore, it is an important for Early Psychosis 
Programs, such as the NL Program, to be successful in reducing depressive symptoms 
in patients. 
The NL Program also reduces suicidal thoughts within the first year. This 
finding was found on the MADRS and the Calgary Depression Scale. It has been 
found that the first year of psychosis is a particular high-risk period for committing 
suicide (Addington et al., 2004b ). Therefore, the NL Program, through its suicide 
prevention education, has been addressing suicidal issues. This study's results are 
similar to Addington et al. (2004b) and V erdoux et al. (200 1) studies, which found a 
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reduction in suicidal attempts after patients were treated in Early Psychosis Programs 
that addressed suicide issues through preventive education. 
It can be concluded that the NL early psychosis program has a significant 
treatment impact for first episode patients. The program reaches its goals of 
promoting recovery and preventing relapse in this (young) age group. Its case 
management, low-dose medication regimes, family intervention, psychotherapy, 
occupational therapy, substance and suicidal counseling has been found to prevent 
substance misuse and suicide; decrease depression; maintain medication adherence; 
improve social and vocational functioning and prevent relapse. The NL Program is 
on par with other early psychosis programs developed in Australia and Canada. 
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CHAPTER6 
CONCLUSION 
6.1 Limitations to this Study 
In conducting this study, there are several limitations that may have had an 
overall effect on the results found. 
The first limitation was in the NL early psychosis database. In some cases, 
the patients were not assessed at all three-month intervals. This maybe due to any 
number of reasons, such as patients missing appointments. This presented a problem 
with sample size to assess the patients at 12, 24 and 36 months. Therefore, in order to 
increase sample size for the analysis, the mean of the assessment months before and 
after the entry points were used if there were no patient data entered at 12, 24 and 36 
months. For example, ifthere was no entry for the 12-month interval, then the mean 
of 9 and 15-month entries were used. This may lead to biases of the results since 
there is no accurate patient measure for that particular point in time to conclude how 
the patient performed at the time interval. 
The second limitation was in using the CCHS, since the survey was cross-
sectional and did not provide longitudinal data of the population. Therefore, in order 
to compare the NL early psychosis patients with the CCHS at two points in time, two 
cohorts from the CCHS population had to be used. This may have lead to biases of 
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the results since only the NL Program database provided longitudinal data of its 
patients. 
The third limitation of this study is that the CCHS is self-rated while the early 
psychosis program scales are professionally rated. Therefore, the responses given in 
the CCHS are subjectively reported and may not be properly diagnosed. This may 
lead to questions being interpreted differently by the person taking the survey 
compared to how the psychiatrist would have interpreted and answered the questions. 
The fourth limitation is that while the questions between the survey and the 
early psychosis scales are matched as closely as possible, the wording and rating 
scales used are not always identical. This leads to some degree of discrepancy in 
interpreting the results since the wording for each questions are not written exactly. 
The fifth limitation is that in order to perform propensity matching to calculate 
individual propensity scores and match as closely as possible between the two groups 
requires a large national population. Two major criteria to propensity match to the 
NL Program were that the CCHS population also had psychosis and was of the same 
age. Unfortunately, only 132 people in the CCHS had psychosis. Therefore, 
propensity matching could not be performed as described by Ascher-Svanum et al. 
(2003) and Shenyang et al. (2004) described in the literature review. 
The sixth limitation is that there may be bias in the results due to multiple 
comparisons. It is known that the more comparisons made will increase the 
likelihood that one of the comparisons will come out statistically significant by 
random chance. However, since two methods were tested, the results did find 
112 
consistency of statistical significance on various variables across the methods to 
suggest that the significant results found were unlikely to occur by random chance. 
6.2 Implications For Future Studies 
This research tests a novel methodology on a unique population. The results 
found propensity match to be useful in evaluating early psychosis programs on 
clinical and social outcomes. Therefore, this method may serve as a model for future 
program evaluations in mental health research. 
It would be interesting in future studies to perform propensity matching by 
matching early psychosis patients from one program to early psychosis patients from 
another program. For example, the NL Program could be compared to the NS 
Program. Propensity matching could be performed as by Ascher et al. (2003) 
whereby propensity scores could be calculated by matching on age, gender, marital 
status, living circumstances and area. Then the individuals with the closest 
propensity scores could be matched on several clinical and social outcomes. This 
would be a way to evaluate the NL Program to see if the patients do as well as 
patients in comparable programs elsewhere in the country or the world. 
A future study may also look at the NL patients 3 or 4 years later to see if after 
completing the program, the patients continue to improve and converge towards the 
population on the same clinical and social outcomes. This would be a true test of the 
overall impact the NL Program is having on normalizing patient quality of life 
outcomes. 
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6.3 Overall Conclusion 
This study evaluated the impact of the NL Program by using a traditional 
methodology and by testing a new methodology, propensity matching. The study 
found that both methodologies show improvement by patients on social and clinical 
outcomes within the first and second year, suggesting the NL Program is effectively 
helping its first episode patients improve and recover through its pharmacological and 
non-pharmacological interventions. 
As well, the study indicates that propensity matching offers a new way to 
evaluate early psychosis programs whereby randomization into the program is not 
always ethical, and whereby pre-post methodology has limitations since it does not 
use a control group, and maturation of the patients maybe the cause of the pre-post 
changes seen. Propensity matching may be a reliable methodology to use when 
evaluating programs. 
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• Supervisor: Dr. Rick Audas 
Telephone Number: (709) 777-7395 
Email: raudas@mun.ca 
• Research Coordinator (if relevant) 
Telephone Number: 
Email: 
2. Title of study 
Outcome Evaluation of an Early Psychosis Program Using Propensity Matching Scores 
3. Study timeline: 
• Proposed start date [at least 4 weeks from date ofsubmissionj: 02/20/05 
• Anticipated completion date: 08/31/05 
• Deadline for ethics approval: 01/20/05 
Indicate below if: 
[ ] course project 
4. Setting of study and data sources: 
• Setting- Please specify the institutions and/or communities involved: 
(i.e. HSC, Janeway, Sr. John's, etc) 
Early Psychosis Program, HCCSJ 
• Check relevant data sources 
(a) Patients [ ) 
(b) Health Providers [ l 
(c) Clinical Records [ ] 
(d) Pre-existing Dataset [X ] [Please gi~·e name of data holder with contact informatio~tj: 
Early Psychosis database and the Canadian Community Health Survey database: 
l\'h. Alison Edwards, Community Health, HSC, (709) 777-6218, aedwards@mun.ca 
(e) Residents in Community [ ] 
(f) Archived Specimens [ ] 
(g) Other [please specify] 
!j tlSing data prevwusly collectedfur another pwpnse (secondary use of data) coptes r.!f the 
leiter requesting iJ?formatirm winch descnh.:s the information sought and of the letterfrmn 
the Jato K1wrdwn approving acces,,· must he offach~d. See Apphca/ion G1ode/mes. 
5. Objectives: 
Provide a numbered list of the main research objectives of the study in plain language {no more 
than 15 lines I 
I. To evaluate the impact of the NL Early Psychosis Program for patients, their 
families and the community on a number of clinical and social outcomes. 
2. To use a new methodology, propensity matching scores, to match psychosis patients 
with the general population on demographic variables to eliminate baseline differences 
since randomization into the program is not feasible. 
3. To use a national database, the Canadian Community Health Survey, as the 
general population for comparison with the early psychosis program patients. 
4. To determine how the patients differ from the general population at entry level into the 
program on variables, such as employment and hospitalizations. 
5. To determine if the patients at the end of the three year program converge back to the 
population mean on the same variables. 
6. To compare and contrast this new methodology with the traditional methodology, 
which evaluates the patients before and after in a program to determine the treatment 
effect of early psychosis programs. 
6. Introduction to the study: 
• What previous work has been done in this area? Summarize previous human studies (no 
more than 20 lines/ 
Psychosis is a medical condition that affects the brain. 3% of all Canadians will 
experience a psychotic episode in their lifetime. It usually occurs in late adolescence-
early adulthood. Symptoms of early psychosis include hallucinations, delusions, bizarre 
behaviours and mood changes. Research has found that psychosis is a treatable 
medical condition, but recovery varies from person to person. 
Several studies have shown that delays in treatment and prolonged duration of 
psychosis is correlated with poorer clinical outcomes and major health care costs, such 
as increased hospitializations. Therefore, detecting psychosis at the earliest possible 
time can reduce symptoms and promote recovery, thereby providing long-term benefits 
for patients and their families. 
Early Psychosis Programs have been developed to reduce delays and improve 
outcomes. These programs are designed to provide structured treatment up to three 
years. McGorry et al. (2003) in Australia and Addington et al. (2004) in Canada have 
evaluated their programs and have found that these programs do reduce delays and 
hospitalizations, provide patient and f:-~mily rounselling and can help lower medication 
dosage. Thus, these programs have clinical and economic benefits. Their studies 
evaluated the programs, by looking at patients before and after in the program to 
lletermine the treatment effect. They assumed any differences were a result of the 
program. 
• What is the rationale for this study, i.e., why are you doing this study? 
1. This is the first time the NL Early Psychosis Program will be evaluated. 
2. Early Psychosis Programs are difficult to evaluate since randomization into these 
programs are not feasible. RCTs are unethical. 
3. Trying to compare early psychosis patients to a control group is also difficult since 
there are baseline differences. 
4. Most studies, therefore, that have evaluated these programs use a pre-post 
methodology, evaluating patients before and after into a program to determine a 
treatment effect. 
5. However this is a methodological flaw. There are no control groups used and they 
assume any changes from before and after are due to the treatment from the 
program. However, since this is a young group, treatment effects may be due to 
natural events (eg. growing older). 
6. Therefore, in evaluations whereby randomization and comparing to a control group 
is difficult, a new methodology, propensity matching, can be used. 
7. Propensity Matching allows matching of a unique group to a control group on 
similar variables to eliminate baseline characteristic differences. 
8. Propensity matching is based on a critical assumption that assumes among 
individuals who are matched on the same characteristics, these individuals can then 
be sorted into treatments as if randomly assigned. 
9. Therefore, with no baseline differences, the groups can then be compared on severa 1 
clinical and social outcomes, such as employment, substance use and 
hospitalizations, to evaluate if the progr-am has helped patients improve. 
I 0. This is the first time an Early Psychosis Program will be evaluated using Propensity 
Matching. 
• Why is this research important? What contributions could it make? 
7. 
This research will test a new methodology on a unique population, whereby 
randomziation and comparing to the general population has been difficult with 
traditional evaluation methods. The results will then be compared to traditional 
evaluation results. If this methodology does prove to be more useful in evaluating 
unique population programs, then this method may serve as a model for future 
program evaluations in mental health research. 
Blood or other tissue sampling which is part of the study: Not Applicable ( X 
• List samples to be taken from participants. the frequency of sampling and the amount of 
sample 
• Will any samples be kept after the completion of this study? 
[lfyes, yo11 musl rnclude ·'Storuge of TISsue·· m the crm.sentfurml 
• Can par11cipants withdraw their blood, tissue or other sample'' 
ff_ve.\, please descrrhe the proces.Y of wtrhdrowa/ / 
Yes ( I No [ I 
Yes[] No[ l 
• \Viii any samples now archived by a health care InStitution he used in the studv'' 
Yes [] No [ ] 
8 Research interventions and/or modes of data collection: 
• List any interventions which would not be part of a participant's daily life. 
• List questionnaires, information sheets, covering letters, telephone or face to face interview 
scripts/outlines or chart audit forms to be used. Include copies of each with each copy of the 
application; if standard questionnaires are being used- SF36, EROTC, etc. [see list on HfC 
website} include one copy only. 
9. Description of study: 
Give a brief description of the study, including interventions and outcome measures in plain 
language [no more than 20 lines/. Describe briefly what the patient will be asked to do. Attach 
one copy of the protocol if relevant. 
This study will evaluate the impact of the NL Early Psychosis Program. The study will 
first compare patients with the general population who have psychosis, and then secondly, 
compare to the entire population at the same age. The Psychosis program has 145 patients_ 
The two sets of controls will be taken from 30,000 people in the Canadian Community 
Health Survey. Matching will be done by Propensity Matching Scores to remove baseline 
differences. The variables to use are age, gender, geography and medical history. 
Matching will be done by matching early psychosis questions on these variables with the 
most similar questions used in the survey database. Using SPSS on these selected variables, 
a propensity score will be calculated for each individual. An early psychosis patient is then 
randomly selected and matched with a control with the closest propensity score. Both 
individuals are then removed from further matching, and a new patient is selected until 
they are all matched. Using SPSS, they will then be compared on outcome variables. First, 
they are compared, to see if the patients differ from the population at entry, and then are 
compared at the end of the program, to see if the patients converge towards the population. 
The outcome variables to use are education, employment, substance use, depression, social 
support, hospitalizations, and suicide. Again, the questions from both databases are 
matched as closely as possible. Logistic regression and t-tests will be C()nducted on the 
data. The results will then be compared to traditional methodological results to see which 
method shows a greater program treatment effect. 
10. Sample size: {if measuring .'itcttistical differenceslequiwtlem:ie.'ij 
G1ve the basis- power. alpha. dtfference to be detected. etc, for the choice of sample size 
There will be no calculation of sample size for the proposed study. The Early Psychosis 
database has 145 patients. Therefore, 145 people with a potential diagnosis of psychosis 
out of 30,000 fr-om the Canadian Community Health Sur-vey, will be used liS an ahnormal 
control group to match the 145 early psychosis patients. The early psychosis patients will 
also be matched by age to a normal control group from the Canadian Community Health 
Survey. All matching will be done by propensity matching. 
ll. Participants: 
• Describe the participants to be contacted or whose record information will be used. 
(a) Adults [X ] (b) Children under 19 [X] 
(c) Persons incompetent to give consent [ ] (d) Protected or vulnerable populations [ ] 
If including children, incompetent adults or persons in protected or vulnerable populations. 
please justify their inclusion in the research study. 
• Number of participants at this site: 
145 patients from Early Psychosis Program. 
145 people from the Canadian Community Health Survey out of 30, 000 who have a 
potential diagnosis of psychosis will be matched to the early psychosis patients. 
145 people from the Canadian Community Health Survey out of 30,000 who do not 
have psychosis, but are of the same age group, will be matched to the early psychosis 
patients. 
• Will pregnant women be excluded? Yes [ J No {X] 
• Is this a part of a national/international study? Yes [ ] No [ X ] 
• Ifyes, what is the total number of participants at all sites . 
• •• · If yes, wh~t¢ i$ the mairt StUQY site? 
• Will contact be made with potential participants? Yes [ ] No [X] records onJy 
[Please specify the means of contact- letter, telephone, advertisement, etc.] 
• Jfyes, who wilt tn~tke the first contact to provide information. about the study? 
(a) Attending physician [ ] 
(c) Other [Please .~pecify] 
(b) Investigator [ ] [See guideline,\] 
12. Consent process: 
• Who will obtain the consent? 
Consent for the creation and use of the Early Psychosis database for the purpose of 
research evaluations has already been approved by HIC. See reference file# 03.218. 
For use of the Early Psychosis database for this study, consent has been obtained from 
Dr. Kevin Hogan, Early Psychosis Program. See attached letter. 
The Canadian Community Health Survey database is a freely available public data file 
for students to use. 
Explain the procedure you will use to obtClin cnnsent 
[If including children, incompetent adults, or persons in protected or vulnerable populations, 
describe in detail how parental or proxy consent will be obtained. See Application 
Guidelines} 
13. Risks, discomforts and inconveniences: No. 
• What risks, discomforts or inconveniences are involved? [See guidelines] 
14. Benefits: 
• Are there any immediate benefits for participants, including controls? 
No. 
15. Privacy and confidentiality: 
• What steps will be taken to protect privacy and confidentiality of information? 
(a) Oath of confidentiality [ X ] 
(b) Locked storage [ X ] 
(c) Limited access (X ] [Please specify method of limiting access] 
(d) Password-protected computer files [ X) 
(e) Denominalized files provided by data holder to investigator [ X J 
(f) Coded study number [ X ] 
(g) Locked room [ X ] 
(h) Anonymous responses to investigator [ 
• All Early Psychosis Program original data is stored in a locked room at the 
Waterford Hospital. The original files cannot be accessed without permission given 
by the Early Psychosis Program Co-ordinators, Dr. Kevin Hogan and Dr. Kellie 
LeDrew. The Computer files of the patients are password protected and stored in 
the Health Research Unit. The data guardian is Ms. Alison Edwards. The 
Principal Investigator will use these compute.- files throughout the analysis, which 
will be password protected on a personal computer and accessible only by the 
principal investigator, Dr. Rick Audas, Dr. Kevin Elogan, Dr. Kellie LeDrew and 
Ms. Alison Edwards. 
• List below the names of all personnel who can access the identities of study participants 
I. Vanessa Gibbons 
2. Dr. Rick Audas 
3. Dr. Kevin Hogan 
4. Dr. Kellie LeDrew 
5. Ms. Alison Edwards 
16. Debriefing; 
Explain the process, if any, for feedback to the research community, participants, agencies, 
communities. [See guidelines] 
The results of this analysis will be part of a Masters Thesis in Community Health. The 
Program Co-ordinators will be sent a summary report of the findings. Publication(s) ara.d 
presentation(s) of the results are intended. 
17. Payments: Not Applicable (X) 
• Do you intend to reimburse participants for expenses incurred? 
Yes [ ) No [ ) Amount{$ ] 
18. Budget: Not Applicable [ I 
Please attach a copy of the budget to each application including the source of funding 
• Source of funding: Principal Investigator is funded jointly by the Early Psychosis 
Program and Faculty of Medicine 
• 
• Will the budget be administered thr-ough the University Finance Office? Yes (X ) No [ ] 
If no, please specify the person or agency re.\ponsible: 
19. Potential conflict of interest: 
• Is any investigator a shareholder in any company/agency 
funding this study? 
• Will any investigator receive direct financial or other benefit? 
lfyes, please describe 
, Will any investigator receive indirect financial or other benefit? 
(share ~~profits, future royalties, patent rights, eta/ j 
!fyes, please descnhe 
20. Ownership, storage and destruction of data: 
Yes [ J No [X ) 
Yes ( ) No [X ] 
Yes [ ) No [ X] 
• The investigator must he free to publish within 6 months after submitting the 
manuscript to the sponsor for review. Publication of the full study must be assumed no 
longer than 1 year after the completion of the study. In agreement with the Oflice of 
Research, HIC wiliHssume these terms will be negotiater1 in any research contract. 
• Do you intend to destroy the data collected at the end ofthe study? Yes [ ] No [X ] 
If no: 
(a) Please give the anticipated date of destruction: 08/31/12 
(b) In what form will the data be retained, e.g., frozen samples, computer tapes, 
paper? The data from this study will be stored on computer files that will 
have password protected access. 
(c) Where will the data be stored? The data files complied in this study will be 
stored in the Health Research Unit within the Division of Community Health, 
Faculty of Medicine. 
{d) Who will be the data guardian? 
Name: Ms. Alison Edwards 
Contact information: Health Research Unit, USC, (709) 777-6218 
• Will any form of identifier- name, postal code, study code, be retained? Yes [X J No [ ] 
• If yes, please describe the identifiers to be retained and give the rationale for their retention_ 
Numerical identifiers that are associated with individual information will be retained. 
These identifiers will be used to allow fo.- internal linkages only. 
21. Concurrent submissions or approvals: 
Has this proposal been submitted to another REB? If already approved, please include one copy 
of approval. 
No. 
Reminders: 
* The use of personnel and/or resources of the Health Care Corporation of St. John's 
requires the approval of the Researclt Propo.ml Approved Committee (St. John'.<.) 
subsequent to HIC approval. Such approvals mcry also he required by institutions outside 
the HCCSI and/or by regional health hoanh·. 
Forward one copy ofthe checklist, application, budget, consent form and any other 
documents (questionnaires, scripts, etc) for screening to the Human Investigation 
Committee (HIC) Office, Room 1755, Health Sciences Centre, Phone 777-6974 /7719 
Twenty,.fnur copies. submitted in sets, will be required by HIC when the application 
has been screened and allowed to proceed to review 
Signature of principal investigator 
~~ );J -t-Z::/ 1 00 s 
Date Vv- v~ Cf 
Signature of undergraduate/graduate/postgraduate student (if applicable): 
Signature of superv7 /
......., / 
Human Investigation Committee 
Research and Graduate Studies 
Faculty of Medicine 
The Health Sciences Centre 
January 25, 2005 
Reference #05.13 
Ms. Vanessa Gibbons 
Division of Community Health 
Health Science Centre 
Dear Ms. Gibbons: 
APPENDIXD 
Your application entitled "Outcome Evaluation of an Early Psychosis Program using 
Propensity Matching Scores" was reviewed by a Sub-Committee of the Human Investigation 
Committee and full approval was granted. 
This will be reported to the full Human Investigation Committee, for their information, at the 
meeting scheduled for February 3, 2005. 
Full approval has been granted for one year. You will be contacted for annual update before 
January 17, 2006. 
For a hospital-based study, it is your responsibility to seek the necessary approval from the 
Health Care Corporation of St. John's and/or other hospital boards qS appropriate. 
This Research Ethics Board (the HIC) has reviewed and approved the application for the study 
which is to be conducted by you as the qualified investigator named above at the specified study 
site. This approval and the views of this Research Ethics Board have been documented in writing. 
In addition, please be advised that the Human Investigation Committee currently operates 
according to the Tri-Council Policy Statement and applicable laws and regulations. 
Notwithstanding the approval of the HIC, the primary responsibility for the ethical conduct of the 
investigation remains with you. 
We wish you success with your study. 
Sincerely, A . 
- v 
-- v 
John D. Harnett, MD, FRCPC 
Co-Chair 
Human Investigation Committee 
JDH;RSN\Jd 
C Or. C Loomis, Vice-President (Research), MUN 
RichardS. Neuman, PhD 
Co-Chair 
Human Investigation Committee 
Mr. W Miller, Director of Planning & ReseMch, HCCS] 
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APPENDIXE 
RESOURCE ALLOCATION REQUEST 
FOR HUMAN INVESTlGA noN PROPOSALS INVOLVING 
THE HEALTH CARE CORPORATION OF ST. JOHN'S 
· To•complete this application you wttt··neect: 
1. A copy of your spending budget (if applicable) 
2. A copy of any applfcable Oepertmental Agreaments 
HIC Ft.,_..nce Number: Ua.11 
Title: "O&d&Pmt Eylfuatlon of 10 E,lftv Psvcbasls PrQSI!liiD Uljnq Pr9R1Dtlty Matching 
I£Dqt"' 
For the Information of the rnen"t~Mra of the Rnearctt Propo.al Approval Committee 
pte ..... tout In a short paragraph an explanation of ttte .tudy you Intend to perform. 
1. To eovalu•te tlte impact ertll• NL Early P5ydl.otis Pro1J111m rer patieatt, their 
ra .. DIH aad dte ~•mmuaity en a Duaber of diD leal and ••~ial outcom•. 
1. T., u.e a new mcthodoloay, propeosity Matchha&teora. to matdl payda.U patieats whit the 
geaeral popalatloa Oil dcmop-apbk viU'iabl• to eliminate bateline differeau. Iince 
raaclomutioa tnto tht pr .... m .. .-ot reuible. 
l. T~ lilt • aadonaJ database. U.t Canadian Community Health Suney, as the 
'totnl popalatioa for comparison "'ith tbe early psydlotia proaram patitntJ. 
4. Tr. detet"mlne how the p•tientt dift"tr rroaa the aeneral population at entry levellnto the 
prouam on v•mbles, Jttth • employment and ho,pttalizatioda. 
!. To delermbae if the pacieott at tb• eod of tbe three yer.r program uuvcr1t back to tht 
population meAD on tho ,. .. , variables. 
6. To co-..pare and .:ontrut thil new methc.dolol)' with the traditional methodology, wllida 
eval.-•tN tile patienta tHtfort and after in a program to determhtc tbe treatment tffect of early 
psychMit programs. 
FEB-II' 05(FRII 11:57 COMMUNITl M£01CINE '7097377l8l r. u 
, . Does this proposal involve the use of m•dication (includng placebOs) other than those 
normally uMd ror patients? ves < 
) NO(X) 
(A) If yes, Please specify 
(B) VVift medeatlona (Actiw or Placebo) 
be dispensed by the Hospital Pharmacy? YES () NO 
X) 
(C) Who will be responsible for the cost of any medlcaUons? NIA 
(0) vvttat \Viti be the c:ost to the Hospital 
Pharmacy (Total or per subject)? N/A 
2. Does the proposal irwotve laboratory tests, x·rays or other Imaging techniquee other 
than required for normal patient care? 
3 
YES() NO (X) 
(If yes, please attach a copy of yo11 Departmental Agreement) 
(A) Please attach a copy of your spending budget. N/A 
(B) Estimate cost (Total or per eubject) _NtA 
(C) \Nho will be reepon$ible for the cost of these tests? NIA 
Does tne proposal require assistance of nun~es or other hQ'Pitel staff? 
YES () NO (X) 
(A) If yes, please describe 
(B) How much time {per subject cr total N/A 
4. Does tho proposal invof"a admission of Aubjeds to the hospital or the clinical 
investigation unit? 
YES () NO (X) 
Please describe I em U!IQ.Q par:tJclpantt alrudy admllt!d to the Early f!tvchosta 
Program 
5 I& this proposal beiog formally sponsored by any agency. pharmaceutical company, 
ate? 
YES() NO (X) 
Ase they responsible for any costs associated with the S1Udy? 
) NO (X) 
YES 
Tht approval of this proposal It oontingent upon the resecwcher providing regularly or upon 
request sn update/on the progress of the research. 
rES·· II' OS (FRII 11 :S? COMMUNITY MEDICINE ?097377382 
SIGNED: 1 ~ Principal tnve&ttgator k!S Date 
iOJ C;Ctinlcal ChiefiOireetor of Program 
~- p _S ... pcrt/.'s« . 
Ail &igna1Ur8S ate ,..q.L--... to NYIIIW & approval by~ Research pmposal Approval 
committee (a sub-CC;;;;'tt;r;f MAC. Health Care Corporation of St. JOhn's). 
1:'. 0 
Health Care 
Corporation of St. John's 
Ms. V. Gibbons 
Grad Student, Community Medicine 
C/o Dr. R. Audas 
Faculty of Medicine 
Memorial University ofNewfoundland 
Dear Ms. Gibbons: 
APPENDIX F 
March 11, 2005 
Your research proposal "HJC # 05.013 Outcome evaluation of an early Psychosis Program 
using Propensity Matching Scores" was reviewed by the Research Proposals Approvals 
Committee (RPAC) ofthe Health Care Corporation of St. John's at its meeting on March 10, 
2005 and we are pleased to inform you that the proposal has been approved. 
This approval is based on the understanding that it has the necessary funding and that it is being 
conducted as outlined in the approved research proposal. Additionally, the Committee requires a 
progress report to be submitted annually and upon completion of the project, the committee 
would appreciate receiving copies of any published articles, abstracts or conference 
presentations. This information would be used to facilitate knowledge dissemination within the 
Health Care Corporation of St. John's. 
If you have any questions or comments, please contact Lynn Purchase, Manager of the Patient 
Research Centre at 777-7283. 
Sincerely, 
II 
1/f' • ~·· ---
Mr. Wayne Miller 
Director, Planning and Research 
Chair, RPAC 
cc Ms. Lynn Purchase, Manager, Patient Research Centre 
Dr. R. Audas, Faculty of Medicine, MUN 
St. Cla;-e's Mercy Hospital 
APPENDIXG 
MATCHED QUESTIONS BETWEEN CCHS & EPP 
CCHS QUESTION EPP QUESTION MATCHED QUESTION 
(SCRB _ 082) In general, CGI Scale: Severity of Mental Health Status: 
would you say your mental Illness: 0= Not stated (EPP(O) not 
health is: (0) Not assessed assessed) 
( 1) Excellent (1) Normal not ill at all 1 = Excellent (EPP( 1) 
(2) Very Good (2) Borderline mentally normal not ill at all) 
(3) Good ill 2= Very Good (EPP(2) 
(4) Fair (3) Mildly borderline mentally ill) 
(5) Poor (4) Moderately Ill 3= Good (EPP(3) mildly ill) 
( 6) Not stated (5) Markedly Ill 4=Fair (EPP(4) moderately 
(6) Severely Ill ill) 
(7) Among the most 5=Poor (EPP markedly 
extremely ill ill(5), severely ill (6) and 
patients among the most extreme ill 
patient(?)) 
(DISB_10e) In the last BAS: Distress Related to Distress Related to 
month, did you feel restless Restlessness: Restlessness: 
or fidgety? (0) No distress 0= No distress (CCHS 
(1) All of the time (1) Mild ( 5)none of the time) 
(2) Most of the time (2) Moderate 1 = Mild (CCHS ( 4)1ittle of 
(3) Some of the time (3) Severe the time) 
(4) Little of the time 2= Moderate (CCHS (3) 
(5) None of the time some of the time) 
3= Severe (CCHS all ofthe 
time(l) and most of the 
time (2)) 
(DISB_10f)In the last ESRS: Restless, nervous, Restlessness: 
month, you felt so restless unable to keep still: 1 =Absent (CCHS 5) 
you could not sit still? (1) Absent 2=Mild (CCHS 4) 
( 1) All of the time (2) Mild 3=Moderate (CCHS 3) 
(2) Most of the time (3) Moderate 4=Severe (CCHS 1 & 2) 
(3) Some ofthe time (4) Severe 
(4) Little ofthe time 
(5) None ofthe time 
(DEPB _ 21) People with Calgary Depression Scale Depressive Symptoms: 
episodes of being depressed For Schizophrenia: Total 1=Yes (EPP 1,2 & 3) 
often have other problems Depression Scale score 2=No (EPP 0) 
at the same time. These (0) Absent 
include things like feelings (I) Mild 
of self-worth, and changes (2) Moderate 
in sleep, appetite energy (3) Severe 
and ability to concentrate 
137 
and remember. Did you 
have problems like this 
during one of your episodes 
of being depressed? 
(1) Yes 
(2) No 
(6) Not Applicable 
(9) Not Stated 
(DEPB _26g) During two MADRS: Reduced Sleep Reduced Sleep: 
weeks, did you have a lot (0) Sleep as usual 1=Yes (EPP 1,2,3,4,5,6) 
more trouble than usual (2) Slight difficulty with 2=No (EPP 0) 
either falling asleep or sleep 
waking up too early nearly (3) Sleep reduced 
every night? ( 6) Less than 2 or 3 
(1) Yes hours sleep 
(2)No 
(6) Not Applicable 
(9) Not Stated 
(DEPB_26r) During two MADRS: Concentration Concentration difficulties: 
weeks, did you have a lot Difficulties: 1=Yes (EPP 1,2,3,4,5,6) 
more trouble concentrating (0) No difficulty in 2=No (EPP 0) 
than is normal for you? concentrating 
(1) Yes (2) Occasional 
(2) No difficulties 
(6) Not Applicable ( 4) Difficulties in 
(9) Not Stated concentrating which 
reduces ability to read 
or hold a conversation 
(6) Unable to read or 
converse without 
difficulty 
(DEPB_26v) During two MADRS: Pessimistic Pessimistic Thoughts 
weeks, did you feel totally Thoughts l=Yes (EPP 1,2,3,4,5,6) 
worthless? (0) No pessimistic 2=No (EPP 0) 
(1) Yes Thoughts 
(2) No (2)Fluctuating ideas of 
(6) Not Applicable failure, self-reproach or 
(9) Not Stated self depreciation 
( 4 )Persistent self-
accusations 
( 6)Delusions of ruin, 
remorse or 
unredeemable sin 
(DEPB_a) Think ofthe Calgary Depression Scale: Suicidal Thoughts: 
period of two weeks or Suicidal Thoughts l=Yes (EPP 1,2,3) 
longer when your feelings (0) Absent 2=No (EPP 0) 
138 
of being depressed and (1) Mild 
other problems were most (2) Moderate 
severe and frequent. (3) Severe 
During that time, did you 
seriously thought about 
committing suicide or 
taking your own life? 
(1) Yes 
(2)No 
(6) Not Applicable 
(9) Not Stated 
(DEPB_28a) Two weeks or MADRS: Lassitude Lassitude: 
longer, how often were you (0) Hardly any 1 =None (EPP 0) 
unable to carry out your difficulty in starting 2= Rarely (EPP 2) 
daily activities because of (2) Difficulty in starting 3= Sometimes (EPP 4) 
your feelings ofbeing activities 4=0ften (EPP 6) 
depressed? ( 4)Difficulty in starting 
(1) Often simple routine tasks 
(2) Sometimes ( 6)Complete lassitude, 
(3) Rarely needs assistance 
(4) Never 
(9) Not stated 
(DEPBFSLA) Did you ever Calgary Depression Scale Suicide Attempt: 
attempt suicide in your Suicide Attempt: 1=Yes (EPP 1,2,3) 
lifetime? (0) Absent 2=No (EPP 0) 
(1) Yes (1) Mild 
(2)No (2) Moderate 
(6) Not Applicable (3) Severe 
(9) Not Stated 
(MIAB _ 06) A period of YMRS: Irritability Irritability: 
several days when you were (0) Absent 1=Yes (EPP 1,2,3,4) 
very irritable or grouchy? (1) Subjectively 2=No (EPP 0) 
(1) Yes increased 
(2)No (2) Irritable during 
(6) Not Applicable interview 
(9) Not Stated (3) Hostile and 
uncooperative 
(MIAB _ 07j) During the MADRS: Reduced Sleep Sleep: 
episode. did you sleep far (O)Sleep as usual 1=Yes (EPP 1.2.3.4.5.6) 
less than usual and still not (2)Slight difficulty with 2=No (EPP 0) 
get tired or sleepy? sleep 
(4)Sleep reduced 
( 6) Less than 2 or 3 
hours sleep 
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(ALCB _1) During the last Case Manager Scale for Alcohol Use: 
12 months, did you drink Substance Use Disorder: 1=Yes (EPP 1,2,3,4) 
alcohol? Alcohol 2=No (EPP 0) 
(1) Yes (0) None 
(2)No (1) Mild 
(6) Not Applicable (2) Moderate 
(9) Not Stated (3) Severe 
(4) Extremely Severe 
(ALDB _14) During the past Case Manager Scale for Continued to drink alcohol 
12 months, did you ever Substance Use Disorder: despite health problem: 
drink alcohol when you Alcohol 1=Yes (EPP 1,2,3,4) 
knew you had a serious (0) None 2=No (EPP 0) 
physical or emotional (1) Mild 
problem that could have (2) Moderate 
been made worse by your (3) Severe 
alcohol use? (4) Extremely Severe 
(1) Yes 
(2)No 
(6) Not Applicable 
(9) Not Stated 
(IDGB _ 02) Have you used Case Manager Scale for Cannabinoids Use 
Marijuana, cannabis or Substance Use Disorder: 1=Yes (EPP 1,2,3,4) 
hashish in the last 12 Cannabinoids 2=No (EPP 0) 
months? (0) None 
(1) Yes (1) Mild 
(2)No (2) Moderate 
(6) Not Applicable (3) Severe 
(9) Not Stated (4) Extremely Severe 
(IDGB _ 05) Have you used Case Manager Scale for Cocaine Use 
cocaine or crack in the last Substance Use Disorder: 1=Yes (EPP 1,2,3,4) 
12 months? Cocaine 2=No (EPP 0) 
(1) Yes (0) None 
(2)No (1) Mild 
(6) Not Applicable (2) Moderate 
(9) Not Stated (3) Severe 
(4) Extremely Severe 
(IDGB_14) Have you used Case Manager Scale for Hallucinogens Use 
hallucinogens in the last 12 Substance Use Disorder: 1=Yes (EPP 1,2,3,4) 
months? Hallucinogens 2=No (EPP 0) 
(1) Yes (0) None 
(2)No (1) Mild 
(6) Not Applicable (2) Moderate 
(9) Not Stated (3) Severe 
(4) Extremely Severe 
(RACB_7a) Because of Quality of Life Scale: Friends: 
your mental condition or Friends 1=Yes (EPP 0,1,2,3,4) 
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health problem, do you Rate 0-6 2=No (EPP 5,6) 
have any difficulty in 
making friends or 
maintaining friendships: 
(1) Yes 
(2) No 
(6) Not Applicable 
(9) Not Stated 
(RACBDPAL) Do you Quality of Life Scale: Activities: 
have difficulty in Activities l=Often (EPP 0,1) 
participating in activities? Rate 0-6 2=Sometimes (EPP 2,3,4) 
(1) Sometimes 3=Never (EPP 5,6) 
(2) Often 
(3) Never 
(9) Not stated 
(RACBF7) Do you have P ANSS: Passive/ Apathetic Passive/ Apathetic Social 
difficulty in social Social Withdrawal Withdrawal: 
situations? (0) Absent 1=Yes (EPP 2,3,4,5,6,7) 
(1) Yes (1) Minimal 2=No (EPP 1) 
(2)No (2) Mild 
(6) Not Applicable (3) Moderate 
(9) Not Stated (4) Moderately Severe 
(5) Severe 
(6) Extreme 
(SSMB_07) Someone to Quality of Life Scale: Interaction: 
have a goodtime with? Interaction O=None of the time (EPP 0) 
(1) None ofthe time Rate 0-6 !=Little time (EPPI) 
(2) Little time 2=Some of the time 
(3) Some of the time (EPP2,3) 
( 4) Most of the time 3= Most of the time 
(5) All of the time (EPP4,5) 
(9) Not stated 4=All of the time (EPP 6) 
(SSMB_03) Some one to Quality of Life Scale: Social Network: 
count on to listen to you Social Network O=None of the time (EPP 0) 
when you need to talk? Rate 0-6 !=Little time (EPPI) 
(1) None ofthe time 2=Some of the time 
(2) Little time (EPP2,3) 
(3) Some of the time 3= Most of the time 
( 4) Most of the time (EPP4,5) 
(5) All of the time 4=All of the time (EPP 6) 
(9) Not stated 
(SSMB _18) Someone to do Quality of Life Scale: Social Activity: 
something enjoyable with? Social Activity O=None of the time (EPP 0) 
(1) None ofthe time Rate 0-6 1=Little time (EPP1) 
(2) Little time 2=Some of the time 
(3) Some of the time (EPP2,3) 
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(4) Most ofthe time 3= Most of the time 
( 5) All of the time (EPP4,5) 
(9) Not stated 4=All of the time (EPP 6) 
(SDCB _ 8) Are you Attending School: School: 
currently attending (1) Yes 1=Yes (EPP 1) 
school/college/university? (2) No 2=No (EPP 2) 
(1) Yes 
(2)No 
(6) Not Applicable 
(9) Not stated 
(LBFBJST) Job status over Employment: Employment: 
the last 12 months? (1) Yes 1=Yes (CCHS 1) 
(1) Job all past year (2) No 2=No (CCHS 2, 3) 
(2) Without a job but 
looking 
(3) Withoutjob 
(SERBG_08) Were you Hospitalization: Hospitalization: 
ever hospitalized for mental (1) Yes 1=Yes (EPP 1) 
health/alcohol/drugs in the (2) No 2=No (EPP 2) 
last 12 months? 
(1) Yes 
(2)No 
(6) Not Applicable 
(9) Not stated 
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